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ABSTRACT 
Surveillance for swine pathogens and health related biomarkers is of great importance to the 
financial success of the swine industry and the health of animal and human populations 
worldwide. Research has shown that the use of oral fluid specimens in diagnostics and 
surveillance provides many advantages over serum.  To discover the full potential of this 
technology many aspects of its use must be evaluated e.g. sample collection and handling 
techniques, assay performance parameters and detection limits of pen-based samples. 
As reviewed in Chapter 1, the detection of many analytes in human and animal oral fluid 
samples has been reported.  In the process of these discoveries, it was been identified that 
oral fluid sample collection material, post-collection processing and sample storage can 
affect testing results of human and animal oral fluid samples.  Though little data was found in 
the literature regarding these effects on animal samples, limited reports suggest they may 
similarly affect veterinary testing of oral fluid specimens.  As more diagnostic tests for 
human and animal oral fluid samples become available, it will be important to consider if and 
how these external factors affect testing results.     
Pursuant to the concerns identified in Chapter 1, the objective of the first research project 
(Chapter 2) was to evaluate the effect of oral fluid sampling material and post-collection 
processing on the results produced by antibody- and polymerase chain reaction-based assays.  
Oral fluid samples were collected from 104 pens of commercial wean-to-finish pigs using 3 
types of rope.  Processed (centrifuged and filtered) and unprocessed oral fluid samples were 
tested using commercial ELISAs for porcine reproductive and respiratory syndrome virus 
(PRRSV) antibodies and total IgM, IgA, and IgG.  Only unprocessed samples were tested for 
PRRSV nucleic acid and processed samples for PRRSV neutralizing antibodies.  It was 
found that all three factors could affect results, but statistically significant effects were non-
uniform and assay-dependent. 
The objective of the second study (Chapter 3) was to evaluate the detection limits of assays 
detecting PRRSV antibodies and PRRS virus in pen-based oral fluid samples from 
commercial swine.  Five successive oral fluid samples were collected from 25 pens of 
commercial swine of known PRRSV prevalence (0%, 4%, 12%, 20% and 36%) with five 
vi 
 
pens per prevalence level.  PRRSV prevalence was established by vaccinating commercial 
swine with an intramuscular modified live PRRSV vaccine 14 days prior to the trial.  The 
vaccinated pigs were then introduced at the designated prevalence levels into pens of 
otherwise PRRSV negative pigs one day prior to sample collection.  Serum was collected 
from each pig in each pen to confirm expected PRRSV prevalence.  Oral fluid and vaccinated 
pig serum was tested using RT-PCR and ELISA by six laboratories.  Intra-laboratory 
agreement was measured and predicted probability of PRRSV detection in pen-based oral 
fluid samples was estimated for each assay.  
vii 
 
INTRODUCTION: THESIS ORGANIZATION 
This thesis is organized in four chapters. Chapter 1 contains a general introduction to the 
thesis organization and a literature review.  The literature review is titled “The influence of 
external factors on the results of oral fluid testing” and will be submitted to the Journal of 
Animal Health Research Reviews for publication.  Chapter 2 is a scientific research paper 
titled “Effect of collection material on pig oral fluid testing results” and has been submitted 
Research in Veterinary Science for publication.  Chapter 3 is the final scientific research 
project titled “Probability of detecting PRRSV infection in pen-based swine oral fluid 
samples”.  This chapter will be submitted for publication in the Journal of Veterinary 
Diagnostic Investigation.  The final chapter contains general conclusions for the entire thesis. 
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CHAPTER 1. THE INFLUENCE OF EXTERNAL FACTORS ON THE 
RESULTS OF ORAL FLUID TESTING 
 
For submission to Animal Health Research Reviews 
 
Chris Olsen, Jeffrey J. Zimmerman 
 
ABSTRACT 
Oral fluid is widely used in human and veterinary diagnostics.  Collection of oral fluid is 
convenient, economical, does not require special training and can be done on-site in both 
humans and animals.  Because oral fluids reflect many of the bioanalytical substances found 
in serum and tissues and is a convenient sample it and has been the focus of significant 
investigation in humans and animals.  Researchers have reported that external factors i.e. 
sample collection material, post-collection sample processing and sample storage can affect 
oral fluid testing results.  Cotton collection materials have reportedly reduced the level of 
antibody, hormones, and total protein in oral fluid.  Sample processing techniques such as 
centrifugation and/or filtration also reduced antibody, hormone and protein measurements.  
Analyte stability is important in all biological samples.  Since oral fluid can be collected in 
the home or on the farm by untrained individuals, shipping samples is common.  Many 
inconsistencies were identified for a variety of targets in oral fluid.  In general, targets are 
stable at freezing temperatures and for short periods of time at refrigeration temperature.  
This review will outline the literature surrounding the effect of external factors on oral fluid 
testing and apply the data to current oral fluid usage in diagnostic medicine.             
 
1.  INTRODUCTION 
The use of oral fluid specimens in disease diagnosis and health monitoring provides many 
advantages over serum and other sample types.  As outlined in recent research reports and 
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reviews, collection of oral fluid is convenient, economical, does not require special training 
and can be done on-site in both humans and animals (Scully, 1997; Hofman, 2001; Gomes-
Keller et al, 2006; Tabak, 2007; Prickett et al., 2008a, 2008b; Kittawornrat et al., 2010; 
Prickett and Zimmerman, 2010).  More importantly, the detection of numerous bioanalytical 
targets in oral fluid has been reported in humans and animals (Table 1). 
Oral fluid is comprised mainly of secretions from three pairs of major salivary glands 
(parotid, sublingual, and submandibular) but also contains components from other sources 
such as serum transudate, oro-naso-pharyngeal secretions, and gingival cervicular fluid 
(Delima and van Dyke, 2000; Aps and Martens, 2005; Cameron and Carman, 2005; Prickett 
and Zimmerman, 2010).  Studies have shown that when fluorescein dye is injected into the 
hind leg of dogs, or ingested by humans it can be detected in the gingival cervicular fluid in 
as little as 30 seconds (Brill and Krasse, 1958; Brill and Björn, 1959).  Because of the 
passage of transudates from serum and tissues into the oral cavity, it has been said that oral 
fluid is a “mirror of the body” (Mandel, 1993) and reflects many of the bioanalytical 
substances found throughout the body.  Therefore it is no surprise that immunoglobulins 
(Brandtzaeg 2007), hormones (Vining et al, 1983), and drugs (Aps and Martens, 2005) have 
been reported to be present in oral fluid as a result of passive diffusion.  
After many years of research, tests are now being utilized in diagnostic laboratories to test for 
targets in human and animal oral fluid.  The first kit for collecting and diagnosing human 
immunodeficiency virus type 1 (HIV-1) antibody in human oral fluid was approved by the 
United States Food and Drug Administration (FDA) in 1994 (Nightingale, 1995).  Since this 
time, several other oral fluid tests for HIV type 1 and 2 have been approved for human use 
(FDA, 2011).  In addition to HIV, the detection of hormones in human saliva is routinely 
practiced and has been reported to be the second most researched topic in human oral fluid 
research (Malamud and Rodrigues-Chavez, 2011).  In pigs, oral fluid is routinely used for the 
detection of porcine reproductive and respiratory syndrome virus (PRRSV) and antibody 
(Kittawornrat et al., 2012; Ramirez et al., 2012), influenza virus (Detmer et al., 2011) and 
porcine circo virus type 2 (PCV2) (Ramirez et al., 2012).  Oral fluid assays for the detection 
of feline leukemia virus in cats (Lewis et al., 1987; Gomes-Keller et al., 2006) and rabies 
virus in dogs (Kasempimolporn et al., 2011) have also been reported.  As shown in Table 1, 
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many other pathogens, hormones, and other biomarkers in humans and animals can be 
detected in oral fluid samples. 
As research surrounding the use of oral fluid developed, studies identified that testing results 
may be influenced by external factors.  Collection material (Table 3), post-collection 
processing (Table 4) and sample storage conditions (Table 5) have been reported to affect 
testing results for antibodies, hormones or drugs.  Little data regarding these topics in 
veterinary applications was found in the literature, but may similarly affect veterinary oral 
fluid testing.  The purpose of this review was to examine and summarize reports that indicate 
collection material, sample processing and sample storage conditions affect oral fluid testing 
results.     
 
2.  TECHNIQUES FOR ORAL FLUID COLLECTION HANDLING AND STORAGE 
Oral fluid can be collected via a variety of methods (Table 2).  Four general techniques have 
been outlined for the collection of oral fluid samples from humans; draining, expectoration, 
suction, or absorption (Navazesh, 1993).  Though expectoration is frequently used in human 
subjects (Kim et al., 2010, Williamson et al., 2012) in other circumstances, it is not desirable 
or is not possible e.g. with animal subjects.  Consequently, absorptive materials are used to 
soak up fluids from the oral cavity (Prickett et al., 2008a, 2008b; Chang et al., 2009; 
Kittawornrat et al., 2010), and thereafter, extracted from the material and used for testing.  
Because of the variety in collection methods in animals and humans, it is important to 
accurately describe the resulting samples using standardized terminology.  Following the 
guidelines outlined by Atkinson et al. (1993), the definitions for “whole saliva”, “the fluid 
obtained…by expectoration” and “oral fluid”, “the fluid obtained by insertion of absorptive 
collectors into the mouth” will be used throughout this review.   
Samples can also be described as stimulated or unstimulated depending on the method of 
collection, or use of chemical stimulants to induce salivary flow (Navazesh, 1993; Schwartz 
et al., 1998; Bergeron et al., 2002).  Samples collected with absorptive materials are often 
considered “stimulated”, whereas samples obtained via expectoration or drooling are called 
“unstimulated” (Atkinson et al., 1993; Navazesh, 1993).  For the purposes of the present 
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work, the main interest lies in the time in which the sample is in the collection material and 
forward.  Therefore, stimulation of salivary flow is of less interest and will not be considered 
in this review.   
Oral fluid is collected from animals using absorptive materials, i.e. a swab or by allowing the 
animals to chew on the collection material (Harley et al., 1998; Prickett et al., 2008a, 2008b; 
Dreschel and Granger, 2009; Kittawornrat et al., 2010).  To collect oral fluid from cattle or 
pigs, collection material e.g. rope, is suspended in the pen, allowing animals to interact with 
the rope and deposit oral fluids (Smith et al., 2004, 2005a, 2005b; Prickett et al., 2008a, 
2008b; Kittawornrat et al., 2010).  In cats and dogs, swabs (Harley et al., 1998; German et 
al., 1998; Kasempimolporn et al., 2000) or dental rope (Dreschel and Granger, 2009) have 
been used to absorb oral fluid from the surfaces on the inside of the mouth. Based on the 
terminology used in this report, samples collected by these methods from animals will be 
considered oral fluid. 
 
3. EFFECT OF COLLECTION MATERIAL ON TESTING RESULTS 
The detection of pathogens and pathogen-specific antibodies has been widely used in human 
and veterinary diagnostics (Prickett et al., 2008a, 2008b; Pink et al., 2009; Kittawornrat et al., 
2010; Delaney et al., 2011; Detmer et al., 2011; Malamud et al., 2011; Ramirez et al., 2011; 
Kittawornrat et al., 2012).  Over the past few decades it has become evident that 
measurements of antibody in oral fluid samples can be influenced by the material used to 
collect the samples.  Total immunoglobulin M (IgM), A (IgA), or G (IgG) measurements 
were reportedly reduced in association with cotton collection materials in human oral fluid 
specimens (Aufricht et al., 1992; Shirtcliff et al., 2001; Strazdins et al., 2005; Michishige et 
al., 2006; Chang et al., 2009).  Chang et al., (2009) also reported a reduction of IgM, IgA and 
IgG in samples collected with polystyrene materials.  In pigs, samples collected with cotton 
had lower concentrations of total IgM, IgA and PRRSV neutralizing antibody titers in 
comparison to samples collected with hemp or nylon (Olsen et al., 2012).  IgG and PRRSV-
specific IgG antibodies were not affected by any of the materials used in this study but 
detection of PRRS virus by RT-PCR was significantly reduced in samples collected with 
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hemp or nylon. 
Measurement of hormones e.g. 17- hydroxyprogesterone (17-OHP) (Kruger et al., 1996), 
cortisol (Levine et al., 2007), DHEA (Johnson et al., 2002), testosterone (Dabbs et al., 1993), 
and progesterone (Gombe, 1977) in biological samples is a useful tool to monitor various 
psychological, developmental, physiological or health-related paradigms (Granger et al., 
1999).  Considerable evidence has suggested that assay results for the detection of hormones 
in human oral fluid are affected by the material used to collect the sample (Table 3).  The 
reported effects of sampling material on assay results however, were not consistent.  
Measurements of cortisol were reportedly increased (Strazdins et al., 2005; Atkinson et al., 
2008) or decreased (Shirtcliff et al., 2001; Gröschl et al., 2008; Hansen et al., 2008) in 
samples collected with cotton.  Similarly, testosterone levels in oral fluid collected with 
cotton were increased (Shirtcliff et al., 2001; Granger et al., 2004; Atkinson et al., 2008) or 
decreased (Gröschl et al., 2008).  Samples collected with polyester materials resulted in 
increased DHEA (Granger et al., 1999) and testosterone (Granger et al., 2004).   
It is evident that there is a need to identify how the reported effects are occurring.  Despite 
significant data identifying the influence material may have on assay results, little data could 
be found supporting a mechanism for the reported effects.  Shirtcliff et al. (2001) 
hypothesized that analytes in the oral fluid sample may bind to fibers in cotton sampling 
materials.  This however does not explain the increased levels of some hormones in samples 
collected with cotton.  It was reported by another author that water absorbed onto four types 
of cotton, extracted, then assayed for testosterone resulted in significantly higher testosterone 
concentrations that water alone (Dabbs, 1991).  In this report the author suggests that 
molecules exist within the cotton, either natively or through manufacturing processes, “that 
mimics the effect of testosterone when assayed” (Dabbs, 1991).  Similar to hormones, it is 
largely unknown how sampling material affects the detection of antibodies, pathogens or 
other analytes in oral fluid samples. 
It is important to consider the differences in experimental design when evaluating the 
reported effects of oral fluid collection material on assay results reported in Table 3.  For 
example, some studies collected saliva from study subjects (pooled or individual), and 
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subjected aliquots to different treatments e.g. in vitro absorption via collection materials or 
collected multiple samples from each subject using different materials.  Additionally some 
studies measured inherent concentrations of analytes in samples whereas others measured 
spiked concentrations of assay targets.  One study (Chang et al., 2009) applied known 
concentrations of total human immunoglobulin diluted in phosphate buffered saline to oral 
fluid sampling devices to test recovery.  The sample size for most human studies was 
relatively small (< 30 subjects), however, multiple studies have reported similar effects 
which support the validity of the reported data.   
 
4. SAMPLE PROCESSING  
Post-collection sample centrifugation is frequently practiced with animal and human oral 
fluid samples (Harmon et al., 2007; Atkinson et al., 2008; Prickett et al., 2008b; Kittawornrat 
et al., 2010) either for the purpose of harvesting the sample from a collection device or to 
clarify the sample.  In veterinary medicine, centrifugation is often performed because many 
field collected oral fluid samples contain significant amounts of manure, feed and other 
environmental particles.  Sample filtration has also been used to further remove particulate 
matter from oral fluid samples.  Consequently, it is important to consider the impact such 
procedures may have on the detection of assay targets.    
Little data was found regarding the effect of oral fluid processing on target detection.  In the 
studies found, the general trend was that processing reduced the results of the respective 
assays (Table 5).  In contrast, cortisol levels were reportedly increased in samples filtered 
through a 0.2 µm filter before testing in comparison to samples which were frozen, thawed 
and centrifuged at 10,000 x g for 10 minutes (Atkinson et al., 2008).  In pig oral fluid 
samples, centrifugation (12,000 x g for 8 hours) significantly reduced the amount of PRRSV 
virus which had been spiked in the sample prior to centrifugation (Rotolo et al., 2012).  Total 
IgM , IgA, and IgG concentrations were also reduced by processing (centrifugation at 10,000 
x g for 2 hours followed by filtration through a 0.22 µm filter) pig oral fluid samples in 
comparison to unprocessed specimens (Olsen et al., 2012).     
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5. SAMPLE STORAGE 
Sample storage is a critical factor for any biological material collected for diagnostic 
purposes.  Oral fluid is increasingly used to gather large-scale epidemiological data (Frerichs 
et al., 1994; de Azevedo et al., 1995; Connolly et al., 2004; Nigatu et al., 2008) from humans, 
and for disease surveillance in pigs (Prickett et al., 2008a; Kittawornrat et al., 2012; Ramirez 
et al., 2012).  Because such samples are commonly collected in the home or on the farm, 
samples often require shipment of samples to a laboratory for analysis. Short-term stability is 
especially critical in these situations to ensure samples arrive in optimal condition.  Because 
oral fluid use is relatively new in diagnostics, the stability of many assay targets is unknown.  
Several reports were found regarding short-term storage of human oral fluid specimens, but 
little data was found for the stability of targets in animal samples (Table 4). 
In regards to short-term storage, general trends were identified based on the data in Table 4.  
Measurements of total immunoglobulin in pig oral fluids appear to be stable for up to 12 days 
at temperatures ≤ 20 °C.  At 30 °C, IgA and IgG isotypes were reduced after 2 days (Prickett 
et al., 2010).  Cortisol measurements in human oral fluid samples were reportedly stable at 
room temperature or 4 °C for 5-7 days (Aardal and Holm, 1995; Clements and Parker, 2005; 
Garde et al., 2005).  The reported effect of other storage conditions and assay targets was 
highly variable with no obvious trends.    
As with studies comparing sampling materials, research methods in storage condition studies 
were highly variable and could not be reflected entirely in Table 4.  Sample handling 
(centrifugation vs. no centrifugation), inconsistent collection methods, and variable freeze-
thaw cycles and testing conditions are all potential sources of inconsistency among the data 
reported.  Nevertheless, it is important to consider the reported effects in future studies of 
oral fluid use.     
  
6. CONCLUSIONS 
Interpretation of the reported data must be done cautiously because of the potential sources of 
variation identified.  Despite inconsistencies, these data can be used as a guideline for future 
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research.  Oral fluid continues to play an increasingly significant role in human (Hart et al., 
2011; Malamud 2011) and veterinary diagnostics (Detmer et al., 2011; Kittawornrat et al., 
2012; Ramirez et al., 2012).  Many factors support the continuation of its use e.g. ease of 
collection, minimal stress on subject of collection, ability to obtain large sample numbers in 
addition to the performance of some diagnostic assays (Delaney et al., 2011; Kittawornrat et 
al., 2012).  The data presented in this review identify areas of this science that may benefit 
from further research.  Understanding the mechanisms by which sample collection materials 
influence assay results will help standardize methods and thereby aid in improved accuracy 
of assay results.  Furthermore, additional data on how storage conditions and post-collection 
processing techniques impact target detection will ensure the integrity of the sample through 
all phases of its collection and use. 
 
7. REFERENCES 
Aardal, E., and Holm, A.C. (1995). Cortisol in Saliva - Reference Ranges and Relation to 
Cortisol in Serum. Clinical Chemistry and Laboratory Medicine, p. 927. 
Aps, J. K., and Martens, L. C. (2005). Review: The physiology of saliva and transfer of drugs 
into saliva. Forensic Science International 150, 119-131. 
Archibald, D. W., Barr, C. E., Torosian, J. P., McLane, M. F., and Essex, M. (1987). 
Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of 
patients with AIDS and AIDS-related complex. The Journal of infectious diseases 155, 
793-796. 
Atkinson, J. C., Dawes, C., Ericson, T., Fox, P. C., Gandara, B. K., Malamud, D., Mandel, I. 
D., Navazesh, M., and Tabak, L. A. (1993). Guidelines for Saliva Nomenclature and 
Collection. Annals of the New York Academy of Science 694, xi-xii. 
Atkinson, K. R., Lo, K. R., Payne, S. R., Mitchell, J. S., and Ingram, J. R. (2008). Rapid 
saliva processing techniques for near real-time analysis of salivary steroids and protein. 
Journal of Clincal Laboratory Analalysis 22, 395-402. 
9 
 
Aufricht, C., Tenner, W., Salzer, H. R., Khoss, A. E., Wurst, E., and Herkner, K. (1992). 
Salivary IgA Concentration is Influenced by the Saliva Collection Method. European 
Journal of Clinical Chemistry and Clinical Biochemistry 30, 81-83. 
Barrett, C., Good, C., and Moore, C. (2001). Comparison of point-of-collection screening of 
drugs of abuse in oral fluid with a laboratory-based urine screen. Forensic Science 
International 122, 163-166. 
Bergeron, R., Scott, S. L., Emond, J. P., Mercier, F., Cook, N. J., and Schaefer, A. L. (2002). 
Physiology and behavior of dogs during air transport. Canadian journal of veterinary 
research = Revue canadienne de recherche veterinaire 66, 211-216. 
Brandtzaeg, P. (2007). Do salivary antibodies reliably reflect both mucosal and systemic 
immunity? Annals of the New York Academy of Sciences 1098, 288-311. 
Brill, N., and Björn, H. (1959). Passage of Tissue Fluid Into Human Gingival Pockets. Acta 
Odontologica Scandinavica 17, 11-21. 
Brill, N., and Krasse, B. O. (1958). The Passage of Tissue Fluid into the Clinically Healthy 
Gingival Pocket. Acta Odontologica Scandinavica 16, 233-245. 
Cameron, S. O., and Carman, W. F. (2005). The use of the OraSure collection device for 
hepatitis virus testing in health care settings. Journal of Clinical Virology 34 Supplement 
1, S22-28. 
Chang, C. K., Cohen, M. E., and Bienek, D. R. (2009). Efficiency of oral fluid collection 
devices in extracting antibodies. Oral Microbiology and Immunology 24, 231-235. 
Christodoulides, N., Mohanty, S., Miller, C. S., Langub, M. C., Floriano, P. N., Dharshan, P., 
Ali, M. F., Bernard, B., Romanovicz, D., Anslyn, E., et al. (2005). Application of 
microchip assay system for the measurement of C-reactive protein in human saliva. Lab 
on a Chip 5, 261-269. 
Clements, A. D., and Parker, C. R. (1998). The relationship between salivary cortisol 
concentrations in frozen versus mailed samples. Psychoneuroendocrinology 23, 613-616. 
10 
 
Connolly, C., Shisana, O., Colvin, M., and Stoker, D. (2004). Epidemiology of HIV in South 
Africa--results of a national, community-based survey. South African Medical Journal 
94, 776-781. 
Cook, C. E., Amerson, E., Poole, W. K., Lesser, P., and O'Tuama, L. (1975). Phenytoin and 
phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. 
Clinical Pharmacolgy and Therapeutics 18, 742-747. 
Corthier, G., and Aynaud, J. M. (1977). Comparison of the immune response in serum and 
bucco-pharyngeal secretions following immunization by different routes with a live hog 
cholera virus vaccine (Thiverval strain). Annales de recherches veterinaires Annals of 
veterinary research 8, 159-165. 
Dabbs, J. M., Jr. (1993). Salivary testosterone measurements in behavioral studies. Annals of 
the New York Academy of Sciences 694, 177-183. 
Dabbs, J., James M. (1991). Salivary testosterone measurements: Collecting, storing, and 
mailing saliva samples. Physiology & Behavior 49, 815-817. 
de Azevedo Neto, R. S., Richards, A., Nokes, D. J., Silveira, A. S., Cohen, B. J., Passos, S. 
D., de Souza, V. A., Brown, D. W., Pannuti, C. S., and Massad, E. (1995). Salivary 
antibody detection in epidemiological surveys: a pilot study after a mass vaccination 
campaign against rubella in Sao Paulo, Brazil. Transactions of the Royal Society of 
Tropical Medicine and Hygiene 89, 115-118. 
Delaney, K. P., Branson, B. M., Uniyal, A., Phillips, S., Candal, D., Owen, S. M., and 
Kerndt, P. R. (2011). Evaluation of the performance characteristics of 6 rapid HIV 
antibody tests. Clinical Infectious Diseases 52, 257-263. 
Delima, A. J., and Van Dyke, T. E. (2003). Origin and function of the cellular components in 
gingival crevice fluid. Periodontol 2000 31, 55-76. 
Detmer, S. E., Patnayak, D. P., Jiang, Y., Gramer, M. R., and Goyal, S. M. (2011). Detection 
of Influenza a Virus in Porcine Oral Fluid Samples. Journal of Veterinary Diagnostic 
Investigation 23, 241-247. 
11 
 
Dreschel, N. A., and Granger, D. A. (2009). Methods of collection for salivary cortisol 
measurement in dogs. Hormones and Behavior 55, 163-168. 
Eblé, P. L., Bouma, A., de Bruin, M. G., van Hemert-Kluitenberg, F., van Oirschot, J. T., and 
Dekker, A. (2004). Vaccination of pigs two weeks before infection significantly reduces 
transmission of foot-and-mouth disease virus. Vaccine 22, 1372-1378. 
Figueroa, F., Ohlbaum, A., and Contreras, G. (1973). Neutralizing Antibody Respnse in 
Bovine Serum and Nasal and Salivary Secretions After Immunization with Live or 
Inactivated Foot-and-Mouth Disease Virus. Journal of Infection and Immunity 8, 296-
298. 
Finlay, E. M., Morton, M. S., and Gaskell, S. J. (1982). Identification and quantification of 
dehydroepiandrosterone sulphate in saliva. Steroids 39, 63-71. 
Food and Drug Administration. 2011. Complete list of donor screening assays for infectious 
agents and HIV diagnostic assays. December 7, 2011. 
<http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/L
icensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM080466>. 
Frerichs, R. R., Silarug, N., Eskes, N., Pagcharoenpol, P., Rodklai, A., Thangsupachai, S., 
and Wongba, C. (1994). Saliva-based HIV-antibody testing in Thailand. Aids 8, 885-894. 
Garde, A. H., and Hansen, Å. M. (2005). Long‐term stability of salivary cortisol. 
Scandinavian Journal of Clinical & Laboratory Investigation 65, 433-436. 
Gaskell, S. J., Pike, A. W., and Griffiths, K. (1980). Analysis of testosterone and 
dehydroepiandrosterone in saliva by gas chromatography-mass spectrometry. Steroids 36, 
219-228. 
German, A. J., Hall, E. J., and Day, M. J. (1998). Measurement of IgG, IgM and IgA 
concentrations in canine serum, saliva, tears and bile. Veterinary Immunology and 
Immunopathology 64, 107-121. 
Gombe, S. (1977). Salivary and plasma progesterone and oestrogen during the menstrual 
cycle and pregnancy. East African Medical Journal 54, 476-479. 
12 
 
Gomes-Keller, M. A., Gonczi, E., Tandon, R., Riondato, F., Hofmann-Lehmann, R., Meli, 
M. L., and Lutz, H. (2006). Detection of feline leukemia virus RNA in saliva from 
naturally infected cats and correlation of PCR results with those of current diagnostic 
methods. Journal of Clinical Microbiology 44, 916-922. 
Gomez-Laguna, J., Gutierrez, A., Pallares, F. J., Salguero, F. J., Ceron, J. J., and Carrasco, L. 
(2010). Haptoglobin and C-reactive protein as biomarkers in the serum, saliva and meat 
juice of pigs experimentally infected with porcine reproductive and respiratory syndrome 
virus. Veterinary Journal 185, 83-87. 
Granger, D. A., Schwartz, E. B., Booth, A., Curran, M., and Zakaria, D. (1999). Assessing 
dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of 
children, adolescents and adults. Psychoneuroendocrinology 24, 567-579. 
Granger, D. A., Shirtcliff, E. A., Booth, A., Kivlighan, K. T., and Schwartz, E. B. (2004). 
The "trouble" with salivary testosterone. Psychoneuroendocrinology 29, 1229-1240. 
Gröschl, M., Köhler, H., Topf, H.-G., Rupprecht, T., and Rauh, M. (2008). Evaluation of 
saliva collection devices for the analysis of steroids, peptides and therapeutic drugs. 
Journal of Pharmaceudical and Biomedical Analysis 47, 478-486. 
Gröschl, M., Wagner, R., Rauh, M., and Dörr, H. G. (2001). Stability of salivary steroids: the 
influences of storage, food and dental care. Steroids 66, 737-741. 
Gutierrez, A. M., Martinez-Subiela, S., Eckersall, P. D., and Ceron, J. J. (2009). C-reactive 
protein quantification in porcine saliva: a minimally invasive test for pig health 
monitoring. Veterinary Journal 181, 261-265. 
Hansen, A. M., Garde, A. H., and Persson, R. (2008). Measurement of salivary cortisol--
effects of replacing polyester with cotton and switching antibody. Scandanavian Journal 
of Clinical Laboratory Investigation 68, 826-829. 
Harley, R., Gruffydd-Jones, T. J., and Day, M. J. (1998). Determination of salivary and 
serum immunoglobulin concentrations in the cat. Veterinary Immunology and 
Immunopathology 65, 99-112 
13 
 
Harmon, A. G., Hibel, L. C., Rumyantseva, O., and Granger, D. A. (2007). Measuring 
salivary cortisol in studies of child development: watch out--what goes in may not come 
out of saliva collection devices. Developmental Psychobiology 49, 495-500. 
Hart, R. W., Mauk, M. G., Liu, C., Qiu, X., Thompson, J. A., Chen, D., Malamud, D., 
Abrams, W. R., and Bau, H. H. (2011). Point-of-care oral-based diagnostics. Oral 
Diseases 17, 745-752. 
Hoepffner, W., and Hubl, W. (1986). Studies on the diurnal variations of 17-
hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital 
adrenal hyperplasia. Experimental Clinical Endocrinology 87, 189-194. 
Hofman, L. F. (2001). Human Saliva as a Diagnostic Specimen. The Journal of Nutrition 
131, 1621S-1625S. 
Holm-Hansen, C., Tong, G., Davis, C., Abrams, W. R., and Malamud, D. (2004). 
Comparison of oral fluid collectors for use in a rapid point-of-care diagnostic device. 
Clinical and Diagnostic Laboratory Immunology 11, 909-912. 
Inaba, T., Stewart, D. J., and Kalow, W. (1978). Metabolism of cocaine in man. Clinical 
Pharmacology and Therapeutics 23, 547-552. 
Johnson, M. D., Bebb, R. A., and Sirrs, S. M. (2002). Uses of DHEA in aging and other 
disease states. Ageing Research Reviews 1, 29-41. 
Just, W. W., Filipovic, N., and Werner, G. (1974). Detection of delta 9-tetrahydrocannabinol 
in saliva of men by means of thin-layer chromatography and mass spectrometry. Journal 
of Chromatography 96, 189-194. 
Kasempimolporn, S., Saengseesom, W., Huadsakul, S., Boonchang, S., and Sitprija, V. 
(2011). Evaluation of a rapid immunochromatographic test strip for detection of Rabies 
virus in dog saliva samples. Journal of Veterinary Diagnostic Investigation 23, 1197-
1201. 
Kim, M. S., Lee, Y. J., and Ahn, R. S. (2010). Day-to-day differences in cortisol levels and 
molar cortisol-to-DHEA ratios among working individuals. Yonsei Medical Journal 51, 
212-218. 
14 
 
Kittawornrat, A., Prickett, J., Chittick, W., Wang, C., Engle, M., Johnson, J., Patnayak, D., 
Schwartz, T., Whitney, D., Olsen, C., et al. (2010). Porcine reproductive and respiratory 
syndrome virus (PRRSV) in serum and oral fluid samples from individual boars: Will 
oral fluid replace serum for PRRSV surveillance? Virus Research 154, 170-176. 
Kittawornrat, A., Prickett, J., Wang, C., Olsen, C., Irwin, C., Panyasing, Y., Ballagi, A., Rice, 
A., Main, R., Johnson, J., et al. (2012). Detection of Porcine reproductive and respiratory 
syndrome virus (PRRSV) antibodies in oral fluid specimens using a commercial PRRSV 
serum antibody enzyme-linked immunosorbent assay. Journal of Veterinary Diagnostic 
Investigation 24, 262-269. 
Kruger, C., Breunig, U., Biskupek-Sigwart, J., and Dorr, H. G. (1996). Problems with 
salivary 17-hydroxyprogesterone determinations using the Salivette device. European 
Journal of Clinical Chemistry and Clinical Biochemistry 34, 926-929. 
Langel, K., Engblom, C., Pehrsson, A., Gunnar, T., Ariniemi, K., and Lillsunde, P. (2008). 
Drug testing in oral fluid-evaluation of sample collection devices. Journal of Analytical 
Toxicology 32, 393-401. 
Leute, R., Ullman, E. F., and Goldstein, A. (1972). Spin immunoassay of opiate narcotics in 
urine and saliva. Journal of the American Medical Association 221, 1231-1234. 
Levine, A., Zagoory-Sharon, O., Feldman, R., Lewis, J. G., and Weller, A. (2007). 
Measuring cortisol in human psychobiological studies. Physiology and Behavior 90, 43-
53. 
Lewis, M. G., Wright, K. A., Lafrado, L. J., Shanker, P. J., Palumbo, N. E., Lemoine, E. D., 
and Olsen, R. G. (1987). Saliva as a source of feline leukemia virus antigen for diagnosis 
of disease. Journal of Clinical Microbiology 25, 1320-1322. 
Malamud, D., and Rodriguez-Chavez, I. R. (2011). Saliva as a diagnostic fluid. Dental 
Clinics of North America 55, 159-178. 
Mandel, I. D. (1993). Salivary Diagnosis: Promises, Promises. Annals of the New York 
Academy of Science 694, 1-10. 
15 
 
Meiszberg, A., Karriker, L., Zimmerman, J., Irwin, C., and Coetzee, J. (2011). Detection of 
ceftiofur and oxytetracycline in oral fluids of swine with a pen-side competitive ELISA 
test after intramuscular injection. Journal of Veterinary Pharmacology and Therrapeutics 
34, 515-517. 
Michishige, F., Kanno, K., Yoshinaga, S., Hinode, D., Takeshisa, Y., and Yasuoka, S. 
(2006). Effect of Saliva Collection Method on the Concentration of Protein Components 
in Saliva. Journal of Medical Investigation 53, 140-146. 
Navazesh, M. (1993). Methods for Collecting Saliva. Annals of the New York Academy of 
Science 694, 72-77. 
Ng, V., Koh, D., Fu, Q., and Chia, S.-E. (2003). Effects of storage time on stability of 
salivary immunoglobulin A and lysozyme. Clinica Chimica Acta 338, 131-134. 
Nigatu, W., Samuel, D., Cohen, B., Cumberland, P., Lemma, E., Brown, D. W., and Nokes, 
J. (2008). Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody 
surveys. Vaccine 26, 4769-4774. 
Nightingale S (1995). From the food and drug administration: oral fluid specimen test system 
for HIV-1 approved. Journal of the American Medical Association 273: 613 
Olsen, C., Karriker, L., Wang, C., Binjawadagi, B., Renukaradhya, G., Kittawornrat, A., 
Lizano, S., Coetzee, J., Main, R., Meiszberg, A., Panyasing, Y., Zimmerman, J. (2012)  
Effect of collection material on pig oral fluid testing results. Research in Veterinary 
Science (in press) 
Parry, J. V., Perry, K. R., and Mortimer, P. P. (1987). Sensitive assays for viral antibodies in 
saliva: An alternative to tests on serum. The Lancet 330, 72-75. 
Pink, R., Simek, J., Vondrakova, J., Faber, E., Michl, P., Pazdera, J., and Indrak, K. (2009). 
Saliva as a Diagnostic Medium. Biomedical papers of the Medical Faculty of the 
University Palacký, Olomouc, Czechoslovakia 153, 103-110. 
Prickett, J. R., and Zimmerman, J. J. (2010). The development of oral fluid-based diagnostics 
and applications in veterinary medicine. Animal Health Research Reviews 11, 207-216. 
16 
 
Prickett, J. R., Cutler, S., Kinoyon, J., Naberhaus, N., Stensland, W. R., Yoon, K. J., and 
Zimmerman, J. (2010). Stability of Porcine Reproductive and Respiratory Syndrome 
Virus and Antibody in Swine Oral Fluid. Journal of Swine Health and Production 18, 
187-195. 
Prickett, J., Kim, W., Simer, R., Yoon, K. J., and Zimmerman, J. (2008). Oral-fluid samples 
for surveillance of commercial growing pigs for porcine reproductive and respiratory 
syndrome virus and procine circovirus type 2 infections. Journal of Swine Health and 
Production 16, 86-91. 
Prickett, J., Simer, R., Christopher-Hennings, J., Yoon, K. J., Evans, R. B., and Zimmerman, 
J. J. (2008). Detection of Porcine reproductive and respiratory syndrome virus infection 
in porcine oral fluid samples: a longitudinal study under experimental conditions. Journal 
of Veterinary Diagnpstic Investigation 20, 156-163. 
Ramirez, A., Wang, C., Prickett, J. R., Pogranichniy, R., Yoon, K. J., Main, R., Johnson, J. 
K., Rademacher, C., Hoogland, M., Hoffmann, P., et al. (2012). Efficient surveillance of 
pig populations using oral fluids. Preventive Veterinary Medicine 104, 292-300. 
Rogers, N. L., Cole, S. A., Lan, H.-C., Crossa, A., and Demerath, E. W. (2007). New saliva 
DNA collection method compared to buccal cell collection techniques for 
epidemiological studies. American Journal of Human Biology 19, 319-326. 
Rotolo, M., White, D., Chittick, W., Strait, E. L., Prickett, J., Main, R., and Zimmerman, J. 
(2012). A new wrinkle in PRRSV oral fluid PCRs. Proceedings from the American 
Association of Swine Veterinarians 43
rd
 Annual Meeting, Denver, Co. 
Ruhl, S., Berlenbach, P., Langenfelder, S., Horl, D., Lehn, N., Hiller, K. A., Schmalz, G., and 
Durchschlag, H. (2011). Integrity of proteins in human saliva after sterilization by 
gamma irradiation. Applied and environmental microbiology 77, 749-755. 
Ruis, M. A., Te Brake, J. H., Engel, B., Ekkel, E. D., Buist, W. G., Blokhuis, H. J., and 
Koolhaas, J. M. (1997). The circadian rhythm of salivary cortisol in growing pigs: effects 
of age, gender, and stress. Physiology and Behavior 62, 623-630. 
17 
 
Schwartz, E. B., Granger, D. A., Susman, E. J., Gunnar, M. R., and Laird, B. (1998). 
Assessing salivary cortisol in studies of child development. Child Development 69, 1503-
1513. 
Scully, C. (1997). HIV topic update: salivary testing for antibodies. Oral Diseases 3, 212-
215. 
Shannon, I. L., Prigmore, J. R., Brooks, R. A., and Feller, R. P. (1959). Parotid saliva, serum, 
and urine 17-hydroxycorticosteroids following a two-hour intravenous infusion of 
adrenocorticotropin. Journal of Dental Research 38, 1237. 
Shirtcliff, E. A., Granger, D. A., Schwartz, E., and Curran, M. J. (2001). Use of salivary 
biomarkers in biobehavioral research: cotton-based sample collection methods can 
interfere with salivary immunoassay results. Psychoneuroendocrinology 26, 165-173. 
Smith, D. R., Gray, J. T., Moxley, R. A., Younts-Dahl, S. M., Blackford, M. P., Hinkley, S., 
Hungerford, L. L., Milton, C. T., and Klopfenstein, T. J. (2004). A diagnostic strategy to 
determine the Shiga toxin-producing Escherichia coli O157 status of pens of feedlot 
cattle. Epidemiological Infections 132, 297-302. 
Smith, D. R., Moxley, R. A., Clowser, S. L., Folmer, J. D., Hinkley, S., Erickson, G. E., and 
Klopfenstein, T. J. (2005). Use of rope devices to describe and explain the feedlot 
ecology of Escherichia coli O157:H7 by time and place. Foodborne Pathogens and 
Disease 2, 50-60. 
Smith, D. R., Moxley, R. A., Clowser, S. L., Folmer, J. D., Hinkley, S., Erickson, G. E., and 
Klopfenstein, T. J. (2005). Use of rope devices to describe and explain the feedlot 
ecology of Salmonella by time and place. Foodborne Pathogens and Disease 2, 61-69. 
Sreebny, L. M., Zhu, W. X., Schwartz, S. S., and Meek, A. G. (1995). The preparation of an 
autologous saliva for use with patients undergoing therapeutic radiation for head and 
neck cancer. Journal of Oral and Maxillofaccial Surgery 53, 131-139. 
Strazdins, L., Meyerkort, S., Brent, V., D'Souza, R. M., Broom, D. H., and Kyd, J. M. 
(2005). Impact of saliva collection methods on sIgA and cortisol assays and acceptability 
to participants. Journal of Immunological Methods 307, 167-171. 
18 
 
Tabak, L. A. (2007). Point-of-Care Diagnostics Enter the Mouth. Annals of the New York 
Acadamey of Science 1098, 7-14. 
Vining, R. F., McGinley, R. A., and Symons, R. G. (1983). Hormones in saliva: mode of 
entry and consequent implications for clinical interpretation. Clinical Chemistry 29, 
1752-1756. 
Vyse, A. J., Cohen, B. J., and Ramsay, M. E. (2001). A comparison of oral fluid collection 
devices for use in the surveillance of virus diseases in children. Public Health 115, 201-
207. 
Waldman, R. H., Mann, J. J., and Kasel, J. A. (1968). Influenza virus neutralizing antibody in 
human respiratory secretions. Journal of Immunology 100, 80-85. 
Wan, S. H., Matin, S. B., and Azarnoff, D. L. (1978). Kinetics, salivary excretion of 
amphetamine isomers, and effect of urinary pH. Clinical Pharmacology and Therapeutics 
23, 585-590. 
Whembolua, G. L., Granger, D. A., Singer, S., Kivlighan, K. T., and Marguin, J. A. (2006). 
Bacteria in the oral mucosa and its effects on the measurement of cortisol, 
dehydroepiandrosterone, and testosterone in saliva. Hormones and behavior 49, 478-483. 
Williamson, S., Munro, C., Pickler, R., Grap, M. J., and Elswick, R. K., Jr. (2012). 
Comparison of biomarkers in blood and saliva in healthy adults. Nursing Research and 
Practice 2012, 246178. 
 
 
 
  
 
 
 
  
1
9
 
Table 1. Select analytes detected in oral fluid specimens 
 
Target Analyte Species Citation 
Pathogens    
Hepatitis A and B IgG Humans Parry, 1987 
HIV IgA Humans Archibald et al., 1987 
Influenza IgA Humans Waldman, 1968 
 Virus Pigs Detmer et al., 2011 
CSFV Antibody Pigs Corthier & Aynaud, 1977 
PCV2 Virus Pigs Prickett et al., 2008b 
PRRSV Virus, IgM, IgA, IgG Pigs Prickett et al., 2008a, 2008b; Kittawornrat et al., 2010; Kittawornrat et al., 2012 
FMDV Virus, Neutralizing Antibody Pigs Eblé et el., 2004 
 Neutralizing Antibody Cattle Figueroa et al., 1973 
Escherichia coli Bacteria Cattle Smith et al., 2004 
Salmonella Bacteria Cattle Smith et al., 2004b 
FeLV Virus Feline Lewis et al., 1987; Gomes-Keller et al., 2006 
Rabies Virus Canine Kasempimolporn et al., 2011 
Hormones    
17-OHCS  Humans Hoepffner and Hubl, 1986 
Cortisol  Humans Shannon et al., 1959 
  Pigs Ruis et al., 1987 
DHEA  Humans Finlay, 1982 
Progesterone  Humans Gombe, 1977 
Testosterone  Humans Gaskell et al., 1980 
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Table 1. (continued) Select analytes detected in oral fluid specimens 
 
Target Analyte Species Citation 
Drugs    
Amphetamines  Humans Wan et al., 1978 
Barbiturates  Humans Cook et al., 1975 
Cocaine  Humans Inaba et al, 1978 
Marijuana  Humans Just et al., 1974 
Opiates  Humans Leute et al., 1972 
Other    
Antimicrobials  Pigs Meiszberg et al., 2011 
C-reactive protein  Humans Christodoulides et al., 2005 
  Pigs Gutierrez et al., 2009; Gomez-Laguna et al., 2010 
Haptoglobin  Pigs Gomez-Laguna et al., 2010 
 
* Abbreviations: HIV, human immunodeficiency virus; CSF, classical swine fever virus; PCV2, porcine circovirus type 2; PRRSV, porcine 
reproductive and respiratory syndrome virus; FMDV, foot-and-mouth disease virus; FeLV, feline leukemia virus; 17- OHCS, 17-
hydroxycorticosteroid; DHEA, dehydroepiandrosterone 
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Table 2. Collection devices for collecting human oral fluid samples 
 
Device Format and Material Manufacturer Citation 
Dental Rope Cotton rope Not reported Dreschel et al., 2009 
DentaSwabs
®
 Polystyrene sponge on plastic stem Kimberly-Clark Corporation, Draper, UT USA Chang et al, 2009 
Dri-Angle
® 
Cellulose pad Dental Health Products, Inc., Niagra Falls, NY USA Chang et al, 2009 
Gauze sponge Layered cotton sponges Henry Schein Inc., Melville, NY USA Chang et al, 2009 
No. 2 cotton roll Cotton roll Sullivan-Shein, Melville, NY USA Chang et al, 2009 
Omni-SAL Absorptive pad on plastic stem Saliva Diagnostic Systems, Vancouver, WA USA Vyse et al., 2001 
Oracol Foam swab on plastic stem Malvern Medical Developments, Worcester, UK Vyse et al., 2001 
Oragene
TM
 Sponge swab DNA Genotek Inc., Kanata, Ontario, Canada Rogers et al., 2007 
ORALscreen
TM
 Foam rectangle Avitar, Inc., Canton, MA USA Barrett et al., 2001; Chang et al, 2009 
OraSure
®
 Cotton pad on plastic stem OraSure Technologies Inc., Bethlehem, PA USA Chang et al., 2009 
Saliva•sampler® Cotton pad on plastic stem Saliva Diagnostic Systems, Vancouver, WA USA Langel et al., 2008; Chang et al, 2009 
Salivette
®
 Untreated cotton roll Sarstedt, Newton, NC USA Granger et al., 1999 
 “    “ Citric acid treated cotton roll  “              “ Granger et al., 1999 
 “    “ Polyester swab  “              “ Granger et al., 1999 
Toothette-Plus Sponge on plastic stem Sage Products Inc., Crystal Lake, IL USA Holm-Hansen et al, 2004 
UpLink
®
 Sponge on plastic stem OraSure Technologies Inc., Bethlehem, PA USA Holm-Hansen et al, 2004 
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Table 3. Effect of oral fluid sampling material on assay results in relation to a sample of reference from the same source 
 
Target Analyte Species Material Reference Sample Effect Assay Citation 
Total Antibody        
 IgM Humans Cotton Spiked Amount Decreased ELISA Chang et al., 2009 
 “    “ Humans Polystyrene Spiked Amount Decreased ELISA Chang et al., 2009 
 “    “ Pigs Cotton Nylon Decreased ELISA Olsen et al., 2012 
 IgA Humans Cotton Whole saliva Decreased 
EIA, 
ELISA 
Aufricht et al., 1992; Shirtcliff et al., 2001; 
Strazdins et al., 2005; Michishige et al., 2006 
 “    “ Humans Cotton Spiked Amount Decreased ELISA Chang et al., 2009 
 “    “ Humans Polystyrene Spiked Amount Decreased ELISA Chang et al., 2009 
 “    “ Pigs Cotton or hemp Nylon Decreased ELISA Olsen et al., 2012 
 IgG Humans Cotton Spiked Amount Decreased ELISA Chang et al., 2009 
 “    “ Humans Polystyrene Spiked Amount Decreased ELISA Chang et al., 2009 
 “    “ Pigs Cotton Hemp or nylon No effect ELISA Olsen et al., 2012 
Pathogens        
PRRSV 
Neutralizing 
antibody
 Pigs Cotton Hemp or nylon Reduced IFA
 
Olsen et al., 2012 
 IgG Pigs Cotton or hemp Nylon No effect ELISA Olsen et al., 2012 
 Virus Pigs Hemp or nylon Cotton Reduced RT-PCR Olsen et al., 2012 
Other        
 
Total 
protein 
Human Cotton FTC Decreased CBQCA
a 
Atkinson et al., 2008 
 “    “ Human Cotton Whole saliva Decreased Lowryb Michishige et al., 2006 
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Table 3. (continued) Effect of oral fluid sampling material on detection of analytes in relation to a sample of reference from the same 
 source 
 
Target Analyte Species Material Reference Sample Effect Assay Citation(s) 
Hormones        
 17-OHP Human Cotton Whole saliva Increased RIA Kruger et al., 1996 
 Cortisol Human Cotton Whole saliva Increased 
EIA, 
RIA 
Strazdins et al., 2005 ; Atkinson et al., 2008 
 “    “ Human Cotton Spiked Amount Decreased 
EIA, 
LC-
MS/MS 
Shirtcliff et al., 2001; Gröschl et al., 2008 
 “    “ Human Cotton Polyester Decreased RIA Hansen et al., 2008 
 DHEA Human Cotton Whole saliva Increased 
EIA , 
RIA 
Granger et al., 1999; Shirtcliff et al., 2001; 
Atkinson et al., 2008 
 “    “ Human Foam Whole saliva Decreased EIA Atkinson et al., 2008 
 “    “ Human Polyester Whole saliva Increased RIA Granger et al., 1999 
 Progesterone Human Cotton Whole saliva Increased EIA  Shirtcliff et al., 2001 
 Testosterone Human Cotton Whole saliva Increased 
EIA,  
RIA 
Shirtcliff et al., 2001; Granger et al., 2004; 
Atkinson et al., 2008 
 “    “ Human Polyester Whole saliva Increased RIA Granger et al., 2004 
 “    “ Human Cotton Spiked Amount Decreased 
LC-
MS/MS 
Gröschl et al., 2008 
 
* Abbreviations: ELISA, enzyme-linked immunosorbent immunoassay; EIA, enzyme immunoassay; PRRSV, porcine reproductive and respiratory 
syndrome virus; IFA, immunofluorescence assay; RT-PCR, reverse transcription polymerase chain reaction; 17-OHP, 17-hydroxyprogesterone; 
RIA, radioimmunoassay; LC-MS/MS, liquid chromatography with tandem mass spectrometry; DHEA, dehydroepiandrosterone; FTC, Freeze-
thaw-centrifuge (4,000 x g for 10 min) 
a
 3-(4-carboxybenzoyl)quinoline-2-carboxalde-hyde (CBQCA) protein quantitation kit (Life Technoloties
TM
, Foster City, CA USA)  
b 
Protein quantitation via the methods described by Lowry et al., 1951
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Table 4. Effect of post-collection sample processing on assay results 
 
Target Analyte Species Processing/Treatment Reference Sample Effect Assay Citation 
Total 
Antibody 
IgM Pigs 
Centrifuge - 10,000 x g 2 hrs  
and filter (0.22µm) 
Unprocessed sample Reduced ELISA Olsen et al., 2012 
 IgA Pigs 
Centrifuge - 10,000 x g 2 hrs 
and filter (0.22µm) 
Unprocessed sample Reduced ELISA Olsen et al., 2012 
 IgG Pigs 
Centrifuge - 10,000 x g 2 hrs 
and filter (0.22µm) 
Unprocessed sample No effect ELISA Olsen et al., 2012 
Pathogens        
PRRSV Virus Pigs 
Centrifuge -  12,000 x g 12 
hrs 
Unprocessed sample Decreased RT-PCR Rotolo et al., 2012 
 IgG Pigs 
Centrifuge - 10,000 x g 2 hrs 
and filter (0.22µm) 
Unprocessed sample No effect ELISA Olsen et al., 2012 
Hormones        
Cortisol  Humans 0.2 µm  filter FTC sample Increased RIA Atkinson et al., 2008 
  Humans 
Centrifuge - 10,000 x g 10 
min 
FTC sample No effect RIA Atkinson et al., 2008 
  Humans 0.22 µm  filter Unfiltered sample Decreased EIA 
Whembolua et al., 
2006 
Testosterone  Humans 0.2 µm  filter FTC sample Decreased RIA Atkinson et al., 2008 
  Humans 0.22 µm  filter Unfiltered sample Decreased EIA 
Whembolua et al., 
2006 
DHEA  Humans 0.2 µm  filter FTC sample Decreased EIA Atkinson et al., 2008 
  Humans 0.22 µm  filter Unfiltered sample Decreased EIA 
Whembolua et al., 
2006 
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Table 4. (continued) Effect of post-collection sample processing on assay results 
 
Target Analyte Species Processing/Treatment Reference Sample Effect Assay Citation 
Other        
Total protein  Humans 0.2 µm  filter FTC sample No effect CBQCA
a 
Atkinson et al., 2008 
  Humans 
Centrifuge - 10,000 x g 10 
min 
FTC sample No effect CBQCA
a 
Atkinson et al., 2008 
  Humans 0.45 µm Untreated saliva Decreased BCA
b 
Sreebny et al., 1995 
  Humans 
Centrifuge -  5,000 rpm 20 
min 
Untreated saliva Decreased BCA
b 
Sreebny et al., 1995 
  Humans 5 µm filter Unfiltered sample Decreased 
SDS-
PAGE 
Ruhl et al., 2011 
 
* Abbreviations: ELISA, enzyme-linked immunosorbent immunoassay; PRRSV, porcine reproductive and respiratory syndrome 
virus; RT-PCR, reverse transcription polymerase chain reaction; FTC, Freeze-thaw-centrifuge (4,000 x g for 10 min); RIA, 
radioimmunoassay; EIA, enzyme immunoassay; DHEA, dehydroepiandrosterone; SDS-PAGE, sodium dodecyl sulfate 
polyacrylamide gel electrophoresis 
a
 3-(4-carboxybenzoyl)quinoline-2-carboxalde-hyde (CBQCA) protein quantitation kit (Life Technoloties
TM
, Foster City, CA 
USA)  
b 
BCA Protein Assay Reagent (Thermo Scientific, Rockford, IL USA) 
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Table 5. Effect of sample storage on the stability of diagnostic analytes 
 
Target Analyte Species Temperature Storage Time Effect Assay Citation 
Total Antibody IgM Pigs ≤ 30 °C 12 days Stable ELISA Prickett et al., 2010 
 IgA Humans -30 °C 12 months Decreased after 8 months ELISA Ng et al., 2003 
 “    “ Pigs ≤ 20 °C 12 days Stable ELSIA Prickett et al., 2010 
 “    “ Pigs 30 °C 12 days Reduced after day 2 ELISA Prickett et al., 2010 
 IgG Pigs ≤ 20 °C 12 days Stable ELISA Prickett et al., 2010 
 “    “ Pigs 30 °C 12 days Reduced after day 2 ELISA Prickett et al., 2010 
Pathogens        
PRRSV Virus Pigs ≤ 10 °C 12 days Stable RT-PCR Prickett et al., 2010 
 “    “ Pigs 20 °C or 30 °C 12 Days Reduced RT-PCR Prickett et al., 2010 
 Antibody Pigs ≤ 10 °C 12 days Stable ELISA Prickett et al., 2010 
 “    “ Pigs 20 °C or 30 °C 12 Days Reduced ELISA Prickett et al., 2010 
Hormones        
17-OHP  Humans Room Temp 21 days Reduced after 15 days RIA Gröschl et al., 2001 
  Humans 4 °C 21 days Reduced after 15 days RIA Gröschl et al., 2001 
Cortisol  Humans Room Temp 90 days Reduced after one month RIA Garde et al., 2005 
  Humans Room Temp 5 days Stable RIA Clements and Parker, 2005 
  Humans Room Temp 7 days Stable RIA Aardal and Holm, 1995 
  Humans Room Temp 10 days Reduced RIA Whembolua et al., 2006 
  Humans 5 °C 3 months Stable RIA Garde et al., 2005 
  Humans -20 °C, -80 °C 1 year Stable RA Garde et al., 2005 
  Humans -20 °C 9 months Stable RIA Aardal and Holm, 1995 
  Humans -20 °C 1 freeze-thaw  Reduced RIA Aardal and Holm, 1995 
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Table 5. (continued) Effect of sample storage on the stability of diagnostic analytes 
 
Target Analyte Species Temperature Storage Time Effect Assay Citation 
Hormones        
DHEA  Humans Room Temp 10 days Stable RIA Whembolua et al., 2006 
  Humans -80 °C 3 freeze-thaws Stable RIA Granger et al., 1999 
Testosterone  Humans 4 °C 4 weeks Weekly linear increase RIA Granger et al., 2004 
  Humans Room Temp 10 days Decreased RIA Whembolua et al., 2006 
  Humans Room Temp 14 days Stable (in males) RIA Dabbs, 1991 
  
Humans 
Room Temp 14 days 
Increased after 1 week in 
females 
RIA Dabbs, 1991 
  
Humans -20 °C and -40 
°C 
6 Months 
Decreased in high 
concentration samples 
RIA Granger et al., 2004 
  
Humans -20 °C and -40 
°C 
2 years 
Stable in low 
concentration samples 
RIA Granger et al., 2004 
  Humans -80 °C 2 years Stable RIA Granger et al., 2004 
Other        
Genomic DNA  Humans 4 °C 7 days Reduced PCR Ng et al., 2004 
  Humans -70 °C 1 month Reduced PCR Ng et al., 2004 
 
* Abbreviations: ELISA, enzyme-linked immunosorbent immunoassay; PRRSV, porcine reproductive and respiratory syndrome 
virus; RT-PCR, reverse transcription polymerase chain reaction; 17-OHP, 17-hydroxyprogesterone; RIA, radioimmunoassay; 
DHEA, dehydroepiandrosterone; PCR, polymerase chain reaction
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CHAPTER 2.  EFFECT OF COLLECTION MATERIAL ON PIG ORAL FLUID 
TESTING RESULTS 
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ABSTRACT 
The effect of sampling material, sample processing, and collection order on the detection of 
analytes in oral fluid was evaluated.  Oral fluid samples were collected from 104 pens of 
commercial wean-to-finish pigs using 3 types of rope.  Processed (centrifuged and filtered) and 
unprocessed oral fluid samples were tested using commercial ELISAs for porcine reproductive 
and respiratory syndrome virus (PRRSV) antibodies and total IgM, IgA, and IgG.  Only 
unprocessed samples were tested for PRRSV nucleic acid and processed samples for PRRSV 
neutralizing antibodies.  Results were analyzed using a repeated measures ANOVA model and 
Tukey-Kramer adjusted t-tests.  It was found that all three factors could affect results, but the 
effects were non-uniform and assay-dependent.  When testing oral fluid specimens, investigators 
and diagnosticians should be aware of the potential impact of these factors on specific analytes.  
For diagnostic submissions, oral fluid samples should be collected using cotton-based materials 
and undergo minimal post-collection processing.   
 
1.  INTRODUCTION 
A significant body of research has developed over the last century on the presence of 
bioanalytical targets in fluids collected from the oral cavity of humans and animals, including 
antibodies (Coleman and Appleman, 1953; Waldman et al., 1968; Archibald et al., 1987; Parry et 
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al., 1987; Delaney et al., 2011; Kittawornrat et al., 2012), pathogens (Scott et al., 1997; Wang et 
al., 2004; Prickett et al., 2008a, 2008b; Kittawornrat et al., 2010; Prickett and Zimmerman, 2010; 
Detmer et al., 2011; Ramirez et al., 2012), hormones (Vinning and McGinley, 1986; Granger et 
al., 1999; Malamud and Rodriguez-Chavez, 2011), and drugs (Mucklow et al., 1978; Kidwell et 
al., 1998; Pink et al., 2009; Meiszberg et al., 2011).  Because this area has been extensively 
researched, nomenclature in the field is well established.  Thus, “whole saliva" describes “the 
fluid obtained … by expectoration” and “oral fluid” is defined as “the fluid obtained by insertion 
of absorptive collectors in the mouth” (Atkinson et al., 1993).   
Consistent with prior research, recent studies in pigs have shown that antibodies (Kittawornrat et 
al., 2012), pathogens (Pricket et al, 2010; Detmer et al., 2011; Ramirez et al., 2012), and 
antimicrobials (Meiszberg et al., 2011) can all be detected in oral fluid specimens.  In pigs, 
samples are collected by suspending absorptive material, e.g., rope, in a pen.  The animals chew 
on the material and deposit oral fluid in this process (Prickett et al., 2008a, 2008b; Kittawornrat 
et al., 2010).  The sample is then harvested by compressing the rope.  Thus, samples collected 
from pigs fit the definition of oral fluid specimens.   
Although the data is sparse, research has shown that the composition of collection materials may 
affect the results of human oral fluid testing.  For example, the concentration of immunoglobulin 
A (IgA) (Shirtcliff et al., 2001; Strazdins et al., 2005; Michishige et al., 2006) and M (IgM) 
(Chang et al., 2009) in oral fluid samples collected with cotton-based materials was lower than 
IgA and IgM in whole saliva samples from the same persons.  Paradoxically, collection of oral 
fluid using cotton materials reportedly increased (Atkinson et al., 2008) and decreased (Gröschl 
et al., 2008) testosterone and progesterone levels, respectively.  Sample processing has also been 
shown to affect some assays.  Atkinson et al., (2008) reported that filtration of oral fluid samples 
(0.2µm polyethersulfone membrane filter) resulted in higher concentrations of cortisol, but lower 
concentrations of testosterone, dehydroepiandrosterone (DHEA), and total protein.  Although pig 
oral fluid samples are increasingly used as a diagnostic specimen, these effects have not been 
evaluated.  Therefore, the objective of this research was to evaluate the effect of oral fluid 
sampling material and post-collection processing on results produced by antibody- and 
polymerase chain reaction-based assays. 
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2.  Materials And Methods  
2.1  Experimental Design  
To compare the effect of sampling material on the detection of analytes in oral fluid, 3 oral fluid 
samples were successively collected from 104 pens of pigs using 3 different types of ropes, i.e., 
cotton, hemp, and nylon.  To control for the effect of sampling order, pens were sampled in one 
of 3 sampling sequences: cotton-nylon-hemp; nylon-hemp-cotton; or hemp-cotton-nylon.  
Following collection, one-half of each oral fluid sample was processed, i.e., centrifuged and 
filtered, and the other half was left unprocessed.  Serum (~5 pigs per pen), and oral fluid samples 
(processed and unprocessed) were tested for PRRSV antibody and total immunoglobulin for each 
isotyope (IgM, IgA, IgG).  Unprocessed oral fluid samples were tested for PRRSV by 
quantitative reverse transcription polymerase chain reaction (qRT-PCR) and processed samples 
for PRRSV neutralizing antibodies.  The effect of sampling material, sample processing, and 
collection order on test results was analyzed using a repeated measures analysis of variance 
(ANOVA) model and Tukey-Kramer adjusted t-tests.  Sample collection protocols and animal 
use was approved by the Institutional Animal Care and Use Committee (6-11-7164-S). 
 
2.2  Barns and Pigs 
Samples were collected from 2 80-pen wean-to-finish barns located in the Midwest USA.  For 
this study, samples were collected from 104 pens; 47 pens from one barn and 57 pens from the 
other.  At the time of collection, each pen contained ~25 pigs weighing 30 to 45 kg (66 – 99lbs).  
The infection status of the pigs was unknown at the time of sample collection.   
 
2.3  Biological Samples 
2.3.2  Oral Fluid 
Blood was collected from a convenience sample of ~5 pigs per pen (n = 516) using a single-use 
blood collection system (Vacutainer
®
, Becton Dickson, Franklin Lakes, NJ USA) and serum 
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separation tubes (Kendall, Mansfield, MA USA).  Blood samples were allowed to clot, 
centrifuged for 10 minutes at 1,000 x g, aliquotted into 2.0 ml cryogenic vials (Fisher Scientific, 
Pittsburgh, PA USA), and stored at -70 °C until tested.   
 
2.3.2  Oral Fluid 
Oral fluid samples were collected using 45 cm (~18”) of 1.27 cm (½”) diameter, 3-strand ropes 
made of cotton (C), hemp (H), or nylon (N).  3 samples were sequentially collected from each 
pen in one of 3 sampling orders (C-N-H, N-H-C, or H-C-N), with approximately one-third of 
pens assigned to each order.  To collect the sample, a rope was attached to the bars at the front of 
the pen, thereby allowing the pigs in the pen to interact with the rope and deposit oral fluid.  
After a 10 minute sampling period, the wet portion of the rope was cut off and placed in a re-
sealable plastic bag (Elkay Plastics, Commerce, CA USA).  This process was repeated until a 
sample had been collected from each pen using each rope type.   
To recover the oral fluid sample, each bag containing a wet rope was slowly pressed through a 
hand wringer (BL-44, Dyna-Jet, Overland Park, KS USA) while the oral fluid pooled in the 
corner of the bag.  When a sufficient quantity of fluid had accumulated, the corner of the bag was 
cut and the oral fluid decanted into a 50 ml centrifuge tube (Fisher Scientific).  Samples were 
subsequently split into 2 aliquots: unprocessed and processed.  Unprocessed samples were 
decanted into 5 ml snap-cap tubes (Becton Dickson) for storage.  Processed aliquots were 
centrifuged at 10,000 x g for 2 hours and then filtered using a 0.22µm syringe filter (Fisher 
Scientific) and placed in 5 ml snap-cap tubes for storage.  Both aliquots were stored at -70 °C 
until assayed. 
 
2.4  Antibody Assays 
2.4.1  PRRSV ELISA 
Serum and oral fluid (unprocessed and processed) samples were randomly ordered 
(www.random.org) and then tested for PRRSV antibodies using a commercial ELISA 
(HerdChek
®
 X3 PRRS ELISA, IDEXX Laboratories, Westbrook, ME USA).  Serum was tested 
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according to the manufacturer’s protocol.  Oral fluid was tested using a procedure based on the 
commercial ELISA (Kittawornrat, 2011; Kittawornrat et al., 2012).  In brief, the PRRSV oral 
fluid IgG antibody ELISA was performed by diluting oral fluid samples 1:2 in kit sample diluent 
and then transferring 250µl of diluted sample onto the antigen plates provided in the kit.  
Negative and positive kit controls were diluted 1:30 using kit sample diluent and 100µl was 
added to the plates.  Plates were incubated at 4 °C for 16 hours (overnight) and then plates 
washed 3 times with 400µl of 1X kit wash solution per well.  Horse radish peroxidase (HRP)-
conjugated antibody was mixed, then added as directed in the modified oral fluid protocol and 
the plates incubated at 22 °C for 30 minutes.  After washing the plates 3 times, 100µl of 
tetramethylbenzidine (TMB) was added to all wells and incubated for 15 minutes at 22 °C. The 
color-developing reaction was stopped by pipetting 100µl of kit stop solution to each well and 
the absorbance was read at 650 nm (EL800, Bio-Tek
®
 Instruments Inc. Winooski, VT USA).  
Results were reported as sample-to-positive ratios (S/P), with responses ≥ 0.40 considered 
positive.   
 
2.4.2  PRRSV Neutralizing Antibody 
Processed oral fluid samples were tested for PRRSV neutralizing antibody using an indirect 
immunofluorescence assay previously described for serum samples (Reed and Muench, 1938; 
Benfield et al., 1992; Christopher-Hennings et al., 2001) and modified for the oral fluid matrix.  
Unprocessed samples were not suitable for testing.  Briefly, oral fluid specimens were treated 
with ultraviolet (UV) light (254nm) at a distance of 2 inches from the sample for 45 minutes to 
inactivate viral and bacterial contaminants, then heat treated at 56 °C for 30 min to inactivate 
bioactive proteins in the sample (Shugars, 1999).  Samples were two-fold diluted (1:2 to 1:64) in 
serum-free Dulbecco's Modified Eagle Medium (DMEM) (HyClone, Thermo Fisher Scientific, 
Waltham, MA USA) and 100µl of diluted sample transferred to each well of a 96-well, round-
bottom cell culture plate (Fisher Scientific).  Thereafter, samples were incubated for 2 hours at 
37 °C with either 50µl of PRRSV (isolate VR-2332 kindly provided by Dr. Eric Nelson) at a 
concentration of 1 x 10
2
 median tissue culture infectious dose (TCID50) or 50µl of PRRSV 
(isolate MN-184 kindly provided by Dr. Michael Murtaugh) at a concentration of 2 x 10
2
.  After 
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incubation, 100µl of the resulting suspension was transferred into a 96-well, flat-bottom tissue 
culture plate (Becton Dickson, Franklin Lakes, NJ USA) containing a confluent monolayer of 
MARC-145 cells and incubated for 2 hours at 37 °C in a 5% CO2 incubator.  Subsequently, 
100µl per well of maintenance medium consisting of DMEM with 2% horse serum (HyClone, 
Thermo Fisher Scientific) was added, after which the samples were incubated for an additional 
48 hours at 37 °C in a 5% CO2 incubator.  Cytopathic effects were visualized by fixing plates 
with 80% acetone water for 10 minutes at room temperature, then incubating for 2 hours at 37
 °C
 
with anti-PPRSV nucleocapsid protein specific monoclonal antibody diluted 1:5000 (SDOW17; 
Rural Technologies, Inc., Brookings, SD USA) and incubating another 2 hours at 37
 °C
 with 
fluorescein fluorophore-conjugated anti-mouse IgGH&L secondary antibody diluted 1:3000 
(Alexa Fluor® 488, Invitrogen, Grand Island, NY USA).  Plates were observed under fluorescent 
microscopy after mounting with 40µl per well of glycerol-PBS (6:4 ratio).  The virus 
neutralization titer (VNT) was determined to be the reciprocal dilution of the sample at which 
>80% inhibition of the PRRSV cytopathic effect was observed. 
 
2.4.3  Total Immunoglobulin Quantitation   
Total immunoglobulin (IgM, IgA, IgG) was quantified in serum and oral fluid (Prickett et al., 
2010; Escribano et al., 2011) using isotype-specific commercial ELISA quantitation kits (Bethyl 
Laboratories, Montgomery, TX USA).  Following the manufacturer's instructions, microtitration 
plates (MaxiSorp
TM
, Thermo Fisher Scientific) were coated with coating antibody (A100-102A 
(IgM),  A100-100A (IgA), A100-104A (IgG), Bethyl Laboratories) by diluting the antibody in 
carbonate-bicarbonate buffer (0.05 M /L, pH 9.6) at a rate of 1:100 and adding 100µl to each 
well.  Plates with coating antibody were incubated for one hour at 22 °C and then washed 5 times 
using 400µl per well (0.05 M Tris, 0.14 M NaCl, 0.05% Tween 20, pH 8.0, Sigma Aldrich).  
Plates were blocked using 200µl per well of blocking solution (0.05 M Tris, 0.14 M NaCl, 1.0% 
BSA, pH 8.0, Sigma Aldrich) and then incubated for 2 hours at 22 °C.  Thereafter, the blocking 
solution was manually emptied from the wells and the plates blotted dry on a paper towel.  
Blocked plates were dried for 2 hours at 37 °C and stored in a sealed plastic bag at 4 °C until use.   
A standard curve was generated on each plate by diluting the provided reference serum (RS10-
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107) to the levels suggested by the manufacturer.  HRP-conjugated antibody (A100-100P (IgM), 
A100-102P (IgA), A100-104P (IgG), Bethyl Laboratories) was diluted 1:50,000 for IgM and 
1:75,000 for IgA and IgG in sample/conjugate diluent (0.05 M Tris, 0.14 M NaCl, 1.0% BSA, 
0.05% Tween 20 pH 8.0, Sigma Aldrich).  Optimal serum sample dilutions were determined by 
performing a 10-fold serial dilution in sample/conjugate diluent.  Final serum sample dilutions of 
1:10,000 (IgM) and 1:100,000 (IgA, IgG) were used.  Optimal oral fluid sample dilutions were 
determined by testing samples diluted at 1:10, 1:50 and 1:500.  Final oral fluid dilutions of 1:50 
(IgM, IgG) and 1:500 (IgA) were used.  Oral fluid or serum samples that exceeded the range of 
the standard curve were re-tested at a two-fold higher dilution than originally used. 
To complete the assay, 100µl of diluted sample was pipetted onto the appropriate plates and 
incubated for one hour at 22 °C.  Plates were washed 5 times, 100µl of the appropriate HRP-
conjugated antibody was added to each well, and incubated for one hour at 22 °C.  Plates were 
washed 5 times and 100µl of TMB was added to each well and incubated at 22 °C.   After 15 
minutes the reaction was stopped by adding 100µl of stop solution (0.05M sulfuric acid) and the 
absorbance read at 450 nm (EL800, Bio-Tek
®
 Instruments Inc.). 
Two in-house oral fluid control samples were diluted appropriately for each assay and run in 
duplicate on each plate.  The OD results from the control samples were used to calculate the 
intra-assay (IgM, IgA, IgG) coefficient of variation (CV) using commercial software (Gen5
TM
 
data analysis software, Bio-Tek® Instruments Inc.).  In this study, an intra-assay CV <10% for 
each control was deemed acceptable and justified the use of inter-plate averages of known-
concentration standards to calculate final immunoglobulin concentrations (Reed et al., 2002). 
Antibody concentration in unknown samples was quantified by fitting a 4-parameter logistic 
regression curve in Gen5
TM
 using the inter-plate average of known-concentration standards.   
Final concentration (mg/ml) was determined by solving the equation for each unknown and 
multiplying the resulting value by the dilution rate of the unknown sample. 
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2.5  Molecular Diagnostics 
2.5.1  Nucleic Acid Extraction 
Oral fluid samples were extracted using the MagMAX
TM
 pathogen RNA/DNA kit
 
(Applied 
Biosystems
TM
) and Thermo Electron KingFisher
®
 automated magnetic particle processor.   Oral 
fluid samples were processed using the protocol for “all other sample types”. Due to limited 
sample volume, "processed" samples were not tested 
 
2.5.2  PRRSV RNA Amplification and Detection via Real-Time PCR  
Real-time PCR was performed with commercially-available reagent sets (TaqMAN
®
 North 
American Reagents and TaqMAN
®
 North American Controls, Applied Biosystems
TM
).  In this 
assay, North American PRRSV RNA are reverse-transcribed into cDNA and amplified by Taq
®
 
DNA polymerase in a single tube, one-step differential (PRRSV Type 1 vs. Type 2) PCR 
reaction.  Detection of amplified target is accomplished by TaqMAN
®
 hydrolysis probe 
chemistry.  This master mix also contains primers and probes targeting an internal positive 
control RNA sequence (Xeno
TM
 RNA-01).  The internal positive control was spiked into the RT-
PCR master mix at a concentration of 100 copies/µl to monitor PCR amplification and allow for 
detection of failed PCR reactions.  
Master mix component volumes per well consisted of 12.5µl of 2X RT-PCR buffer, 2.5µl of 10X 
PRRSV primer probe mix, 2.5µl of 20X multiplex RT-PCR enzyme mix, and 0.35µl of 100 
copies/µl of Xeno
TM
 RNA-01 internal control.  Ultimately, 18µl (rounded up) of master mix was 
combined with 7µl of RNA extract onto a 96-well PCR plate.  Real-time RT-PCR was 
performed (ABI 7500, Applied Biosystems
TM
) using the following cycling conditions: One cycle 
at 45 °C for 10 min, one cycle at 95 °C for 10 min, 40 cycles of: 97 °C for 2 seconds, 60 °C for 
40 seconds.  Quality control of the extraction process included negative (nuclease-free water) 
and positive (PRRSV isolate ISU-P) controls, i.e. nuclease-free water and PRRSV extraction-
positive controls.  Each 96-well PCR plate included a positive amplification control (TaqMAN
®
 
North American PRRSV controls provided by Applied Biosystems
TM
) and a negative 
amplification control (nuclease-free water).  A cycle threshold (Ct) of ≤ 37 was considered 
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positive for PRRSV. 
 
2.6  Statistical Analysis 
Statistical analyses were performed using SAS
®
 Enterprise Guide 4.3 (SAS
® 
Institute, Cary, NC 
USA).  A repeated measures ANOVA model was utilized to analyze the effects of sampling 
material, post collection processing (centrifugation/filtration), and collection order on antibody 
assay results.  PRRSV antibody ELISA data was log transformed to meet distribution 
requirements for valid statistical analyses.  VNT data was log (base 2) transformed to create a 
quantitative data set representative of the original two-fold dilution.  Total antibody (IgM, IgA, 
IgG) concentration and PRRSV antibody ELISA evaluations included material, order, 
processing, and all possible interactions of these factors as fixed effects in the model.  VNT data 
evaluation included material and order as fixed effects.  Pen and the “pen by material” 
interaction were included as random effects in each model.  Least square means were calculated 
and Tukey-Kramer’s adjusted t-test was used to determine statistical significance (p ≤ 0.05) 
among the factors evaluated.   
PRRSV PCR results were analyzed as qualitative (positive/negative) data using a repeated 
measures logistic regression model.  Material and order were included as fixed effects in the 
model and pen was used as a random effect. 
 
3.  RESULTS 
Analyses of oral fluid samples for IgM, IgA, and IgG by isotype-specific quantitative assays and 
analysis of PRRSV-specific diagnostic assays (ELISA, VNT, RT-PCR) are summarized in Table 
1 by factor (sample processing, sampling material, collection order).  Analyses of 516 serum 
samples (516 pigs) for IgM, IgA, and IgG showed mean antibody isotype concentrations of 3.55 
mg/ml, 1.19 mg/ml, and 11.74 mg/ml, respectively.  Comparisons of IgM, IgA, and IgG antibody 
concentrations in serum and oral fluid specimens are given in Figure 1.   
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4.  DISCUSSION AND CONCLUSIONS 
Oral fluid has been described as a diagnostic “mirror of the body” (Mandel, 1993).  In contrast to 
serum, oral fluid collection is "user friendly" both from the perspective of the individual sampled 
and the one collecting the sample.  In pigs, the diagnostic performance of oral fluid-based assays 
supports the premise that this approach could facilitate improved health monitoring and the 
surveillance of economically significant pathogens of pigs, e.g., classical swine fever virus, foot-
and-mouth disease virus, influenza viruses, PRRSV, porcine circovirus type 2, and others 
(Corthier and Aynaud, 1977; Eblé et al., 2004; Prickett et al., 2008a, 2008b; Detmer et al., 2011; 
Kittawornrat et al., 2012; Ramirez et al., 2012).  In humans, it has been reported that both the 
materials used to collect oral fluid specimens and post-collection processing of samples may 
affect assay results (Shirtcliff et al., 2001; Strazdins et al., 2005; Michishige et al., 2006; 
Atkinson et al., 2008; Gröschl et al., 2008; Chang et al., 2009).  Comparable data involving the 
collection of oral fluids from animal subjects could not be found in the literature.  Therefore, the 
current study evaluated the effect of three collection materials (cotton, hemp, nylon) and post-
collection sample processing (centrifugation and filtration) on oral fluid specimens obtained 
from 104 pens of ~25 pigs each.  Because the experimental design mandated 3 successive sample 
collections from each pen, pens were sampled in one of 3 sampling sequences (cotton-nylon-
hemp; nylon-hemp-cotton; or hemp-cotton-nylon) to control for the effect of sampling order.   
Based on the cumulative data (cotton, hemp, nylon) from unprocessed oral fluid samples and 
serum samples from a subset of pigs (n = 5) from the same pen, the concentration of IgM, IgA, 
and IgG in oral fluid was 1/237, 1/14, and 1/783, respectively, the concentration in serum. These 
estimates were similar to previous estimates of total antibody concentrations in oral fluid and 
serum in human samples (IgM 1/400, IgA 1/10, and IgG 1/800) (Parry et al., 1987).  It should be 
noted that estimates of the variation among pigs could be improved by using serum and oral fluid 
from individual pigs, rather than pen-based oral fluids and serum samples from a subset of pigs 
in the pen, as was done in this case.  No statistically significant differences in the concentration 
of IgG (mg/ml) were detected among oral fluid samples collected with cotton, hemp, or nylon 
rope (Table 1, Figure 1).  In contrast, IgM and IgA concentrations differed significantly by 
collection material, with cotton associated with the lowest antibody concentration estimates.  
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Non-uniform, but statistically significant differences were also associated with processing, 
collection order, and the interactions of processing by material.  These results are in agreement 
with prior reports that cotton-based collection materials were associated with lower 
concentrations of IgA and IgM in oral fluid specimens collected from humans (Shirtcliff et al., 
2001; Strazdins et al., 2005; Michishige et al., 2006; Chang et al., 2009).  Overall, IgG antibody 
was the least affected by the factors evaluated.  However, the data indicated that sampling 
material and sample processing should be taken into consideration when collecting oral fluid 
samples for the specific purpose of detecting IgM or IgA antibodies. 
Detection of PRRSV infection in swine populations via testing of oral fluid specimens has 
become commonplace in North America and elsewhere (Prickett et al., 2008a, 2008b; 
Kittawornrat et al., 2010; Prickett et al., 2010; Chittick et al., 2011; Kittawornrat et al., 2012; 
Ramirez et al., 2012).  Analysis of the PRRSV antibody ELISA results showed that both the 
median S/P ratio of the assay and the percentage of positive samples were unaffected by the 
collection material (Table 1).  Consistent with the results from other assays, unprocessed samples 
and the first of the three samples collected had the highest median ELISA S/P ratios.   
The highest rate of PRRS RT-PCR positivity was observed in samples collected with cotton 
material (Table 1).  Prior reports have shown a high correlation between oral fluid and serum 
PRRSV RT-PCR results based on paired samples from individual animals under experimental 
conditions (Kittawornrat et al., 2010).  These results support the use of cotton material for the 
collection of pig oral fluids to be tested using PCR-based assays.   
Although the PRRSV neutralizing antibody assay has not been validated for the oral fluid matrix, 
the presence of neutralizing antibodies in human oral fluid samples has been reported for 
rhinovirus (Douglas et al., 1967), influenza virus (Waldman et al., 1968), mumps (Chiba and 
Nakao, 1972), cytomegalovirus (Tamura et al., 1980), and herpes virus 7 (Ihira et al., 2003).  
Likewise, neutralizing antibodies against foot-and-mouth disease virus were detected in buccal 
fluid samples from cattle and pigs (Figueroa et al., 1973; Archetti et al., 1993; Eblé et al., 2004).  
In both PRRSV type 2 assays, samples collected with cotton materials produced the lowest 
antibody titers and samples collected first among the three collections had the highest antibody 
titers (Table 1).  From these data alone, it cannot be determined whether lower antibody titers in 
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samples collected with cotton were caused by the loss of neutralizing antibody, for example by 
antibody binding to cotton, or if higher neutralizing antibody titers may have resulted from the 
presence of virucidal substances in samples collected with other materials.   
The objective of this investigation was to evaluate the potential effect of sample collection 
material, sample processing, and collection order on porcine oral fluid testing.  The samples 
analyzed in this study were collected from commercial wean-to-finish barns without prior 
knowledge of their health status.  It was found that all three factors could affect results, but the 
effect was non-uniform and assay-dependent.  Depending on the populations' level of immune 
stimulation and infection history, it may be postulated that similar studies in pig populations 
would produce comparable, if not identical, results.  Thus, investigators and diagnosticians 
should be aware of the potential impact of these factors on specific analytes.  In particular, 
diagnostic oral fluid samples should be collected using cotton-based materials and undergo 
minimal post-collection processing.   
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Table 1.  Effect of collection material, sample processing, and collection order on oral fluid assay results (n = 104 pens)  
 
Factors 
Mean Antibody (mg/ml)  Porcine reproductive and respiratory syndrome virus (PRRSV) Assays 
IgM IgA IgG  Antibody ELISA
1 
VN Antibody-1
2 
VN Antibody-2
2 
qRT-PCR (%)
 
Material (univariate analysis)
 
        
 Cotton  (n = 104) 0.010
b
 0.064
c 
0.012
a 
  0.366
a  
(45%)  1:12.4
b 
 1:10.1
b 
 34
a 
(32.7%)
 
 Hemp  (n = 104) 0.013
a 
0.076
b 
0.013
a 
  0.368
a
  (46%)  1:17.9
ab 
 1:14.1
b 
 5
b 
(4.8%) 
 Nylon  (n = 104) 0.013
a 
0.081
a 
0.013
a 
  0.366
a  
(45%)  1:27.2
a 
 1:32.0
a 
 2
b 
(1.9%) 
Processed
1
 (univariate analysis)
  
 
 
   
 NO (n = 312) 0.015
a 
0.088
a 
0.015
a 
  0.414
a
  (46%) Not Tested  41 (13.1%) 
 YES  (n = 312) 0.010
b 
0.059
b 
0.010
b 
  0.324
b
 (45%) 1:18.1 1:16.6 Not Tested 
Collection Order (univariate analysis)
  
       
 1  (n = 104) 0.014
a 
0.083
a 
0.013
a 
  0.388
a
  (45%)  1:21.3
a 
 1:19.2
a 
 16
a
 (15.4%) 
 2  (n = 104) 0.012
b 
0.071
b 
0.012
b 
  0.350
a
  (46%)  1:17.8
b 
 1:16.2
b 
 16
a
 (15.4%) 
 3  (n = 104) 0.011
c 
0.066
b 
0.011
b 
  0.334
b
  (45%)  1:15.8
b 
 1:14.8
b 
 9
a
 (8.7%) 
Process x Material
  
       
No x  Cotton (n = 104) 0.012
a 
0.076
b 
0.014
a 
  0.420
a
  (45%) Not tested  34
a 
(32.7%)
 
No x  Hemp  (n = 104) 0.016
a 
0.093
a 
0.015
a 
  0.426
a
  (46%) "        "  5
b 
(4.8%) 
No x  Nylon (n = 104) 0.016
a 
0.094
a 
0.015
a 
  0.397
a
  (45%) "        "  2
b 
(1.9%) 
Yes x Cotton (n = 104) 0.008
a 
0.051
e 
0.009
a 
  0.318
a
  (45%)  1:12.4
b 
 1:10.1
b 
Not Tested 
Yes x Hemp  (n = 104) 0.011
a 
0.059
d
 0.010
a 
  0.316
a
  (45%)  1:17.9
ab 
 1:14.1
b 
"     " 
Yes x Nylon  (n = 104) 0.011
a 
0.068
c 
0.010
a 
  0.338
a
  (45%)  1:27.2
a 
 1:32.0
a 
"     " 
 
1 
Median PRRSV antibody ELISA S/P values and percent positive samples (IDEXX Laboratories, Inc., Westbrook, ME USA) 
2
 Least squares means of virus-neutralizing (VN) antibody titers based on type 2 PRRSV isolates VR-2332 (1) or MN-184 (2).  
3 
Centrifuged at 10,000 x g for 2 hours and then filtered using a 0.22µm syringe filter (Fisher Scientific, Pittsburgh, PA USA) 
abcde 
Groups not sharing a common letter within columns for each factor are statistically different (p ≤ 0.05)
46 
 
 
 
 
 
Figure 1.  Antibody isotype concentrations in serum, unprocessed
a
, and processed
b
 oral fluid.   
Processed oral fluid samples were centrifuged at 10,000 x g for 2 hours and then 
filtered using a 0.22µm filter 
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ABSTRACT 
The use of oral fluid specimens for pathogen detection in pig disease surveillance systems 
has been effective and has helped to overcome some of the challenges faced with collection 
of individual samples. Pen-based oral fluid sampling allows for the collection of samples that 
represent a large number of animals, but to be effective, the diagnostic assay must be able to 
detect low disease prevalence.  Five successive oral fluid samples were collected from 25 
pens of pigs which consisted of five levels of Porcine reproductive and respiratory syndrome 
virus (PRRSV) prevalence (0%, 4%, 12%, 20% or 36%).  Serum was collected from all pigs 
in the study to confirm disease prevalence.  Serum and oral fluid was tested by six 
laboratories for PRRSV antibodies using an enzyme-linked immunosorbent assay (ELISA) 
and PRRSV via reverse transcription-polymerase chain reaction (RT-PCR).  Analysis of 
intra-laboratory agreement for serum and oral fluid assays revealed that RT-PCR is more 
variable than the PRRSV antibody ELISA.  Predicted probability of detection was calculated 
based on the with-in pen PRRSV prevalence or the level of interaction with the sampling 
material by PRRSV positive pigs.  Probabilities of detection near 100% were achieved with 
samples collected from high prevalence pens.  Overall, this data supports the use of oral fluid 
in PRRSV surveillance in pig populations and demonstrates its value in comparison to serum 
samples.  
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1.  INTRODUCTION 
Surveillance for pathogens in swine populations became increasingly important when swine 
production transitioned to confinement-style systems.
8
.  The use of oral fluid specimens for 
pathogen detection in such systems has been effective and has helped to overcome some of 
the challenges faced with collection of individual samples.
4,6,7,8
  Individual sampling can be 
expensive, labor intensive, and is difficult to obtain a sufficient quantity of samples to 
represent the entire population.  Pen-based oral fluid sampling allows for the collection of a 
sample representative of a larger number of animals, is convenient, and cost-effective.   
A caveat to pen-based oral fluid sampling in disease surveillance is the detection limits of the 
diagnostic assay.  In surveillance programs it is important to have a diagnostic test that can 
detect low levels of disease prevalence.  It has been reported that a porcine reproductive and 
respiratory syndrome virus (PRRSV) antibody ELISA used for PRRSV surveillance is highly 
sensitive and specific when testing known status oral fluid samples.
4
  Studies testing pig oral 
fluids for PRRSV by reverse transcription polymerase chain reaction (RT-PCR) are generally 
in agreement that PRRSV can be readily detected in pen-based samples often times earlier 
than serum.
3,6,7,8
  It has been indicated though that ongoing development is needed to 
continue to increase the sensitivity of PRRSV RT-PCR oral fluid assays
1,8
.  The purpose of 
this study was to evaluate the detection limits of PRRSV ELISA and RT-PCR assays in pen-
based oral fluid samples from commercial swine of known PRRSV prevalence.  
 
2.  MATERIALS AND METHODS 
2.1  Experimental Design 
25 pens of swine in a commercial swine barn were randomly assigned to one of 5 groups. 
Groups consisted of 0, 1, 3, 5 or 9 vaccinated
a
 pigs in a pen (n=25 pigs) of otherwise 
suspected PRRSV negative pigs.  On day 1, the appropriate number of suspected PRRSV 
negative pigs (n=535) were placed in pens and one oral fluid sample was collected from each 
pen.  On day 2, serum was collected from each of the 535 suspected PRRSV negative pigs to 
confirm the PRRSV status of all pigs.  After serum collection, the appropriate number of 
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PRRSV vaccinated pigs (n=90) were placed into each pen.  The following morning (Day 3), 
5 successive oral fluid samples (30 minute sampling period, < 10 minutes between 
samplings) were collected from each pen. During the sampling period, each pen was 
monitored and the number of vaccinated pigs to contact the sampling rope per minute was 
recorded (‘contact events’).  After oral fluid collection, serum samples were collected from 
each of the vaccinated pigs.  Oral fluid (n=150) and vaccinated pig serum (n=90) were 
assayed for PRRSV antibodies and PRRS virus each by six diagnostic laboratories.  A 
portion of each expected negative pig serum was pooled into 107 pooled samples (5 pigs per 
pool).  Pooled serum was assayed for PRRS virus by two diagnostic laboratories.  All 535 
individual serum samples were assayed for PRRSV antibodies by two diagnostic 
laboratories.  Inter-laboratory agreement was measured to compare the assay results from all 
six laboratories for oral fluid and serum (RT-PCR and ELISA).  Predicted probability plots 
were created using logistic regression based on the probability of detecting a positive (ELISA 
or RT-PCR) oral fluid sample depending on the within-pen PRRSV prevalence or the 
number of ‘contact events’ per sampling period.  Sample collection protocols and animal use 
was approved by the Institutional Animal Care and Use Committee (8-11-7201-S). 
   
2.2  Barns and Pigs 
Pigs were housed in commercial swine facilities.
b
  On day -11, a group of nursery age pigs 
were vaccinated intramuscularly with 2 ml of a modified live PRRSV type 2 vaccine.
a  
 
Vaccinated pigs were housed in a separate facility until placed in the trial pens on day 2.  
Suspected PRRSV negative pigs were housed in similar facilities at a separate location until 
the trial.   
    
2.3  Biological Samples 
Pen-based oral fluid specimens were collected as previously described (Kittawornrat et al., 
2012, Prickett et al., 2008).  Briefly, a length of 5/8” (~1.6 cm) 3-strand cotton rope (40 inch, 
~100 cm) was suspended in the pen such that pigs could actively chew on both loose ends of 
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the rope.  Ropes remained in the pen for 30 minutes, after which the saturated portion of the 
rope was cut off and sealed in a plastic bag. 5 successive samples were collected from each 
pen with < 10 minutes between each sampling.  ‘Contact events’ were recorded for each 
sampling and can be defined as the number of times time a vaccinated pig touched the 
sampling rope with a maximum of one contact per pig, per minute for a maximum of 30 
‘contact events’ per pig per sampling period.  After all samples had been collected, each bag 
containing saturated ropes was pressed through a hand wringer
c
 to extract the oral fluid form 
the rope.  Oral fluid pooled in the corner of the bag, the bag was cut, and oral fluid decanted 
into 50 ml centrifuge tubes.
d
  Samples were aliquotted and stored in 2 ml cryogenic vials
d
 at -
70 °C until shipped for testing.   
Serum was collected using a single-use blood collection system
e
 and serum separation tubes.
e
  
Blood samples were allowed to clot and centrifuged for 10 minutes at 1,000 x g to separate 
the serum.  Pooled samples were created from the 535 suspected PRRSV negative pigs by 
pooling an equal portion of 5 samples together creating 107 pooled samples.  The remaining 
serum from each of the pigs was stored in individual aliquots.  Serum from the 90 PRRSV 
vaccinated pigs was stored as individual samples.  Serum samples were stored in 2 ml 
cryogenic vials
d
, at -70 °C until shipped for testing. 
Frozen samples were shipped overnight to participating laboratories in insulated shipping 
boxes on standard ice packs for diagnostic testing.  
 
2.4  Diagnostic Assays 
Serum and oral fluid samples were randomly ordered and tested for PRRSV antibodies and 
PRRS virus via RT-PCR.  Oral fluid (n=150) and vaccinated pig serum (n=90) samples were 
each tested by six laboratories for PRRSV antibodies (Labs 1,2,3,6,7,8) and PRRS virus 
(Labs 1-6).  Suspected PRRSV negative serum from individual pigs (n=535) was tested via 
PRRSV antibody ELISA by two laboratories (Labs 1 and 8).  Pools of these samples (5 
samples per pool, n=107) were tested by PRRSV RT-PCR by two laboratories (Labs 4 and 
5).  If a pooled sample tested positive, standard diagnostic protocols were followed and the 
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individual samples which comprised the respective pool were tested by the same laboratory 
using the same protocol.   
 
2.4.1  PRRSV antibody ELISA 
All laboratories testing serum and oral fluid samples for PRRSV antibodies used the same 
commercial ELISA assay.
f
  Serum was tested according to the manufacturer’s protocol.  Oral 
fluid was tested using a procedure based on the commercial ELISA.
2,4
  In brief, the PRRSV 
oral fluid IgG antibody ELISA was performed by diluting oral fluid samples 1:2 in sample 
diluent provided in the kit, then transferring 250 µl of diluted sample onto the antigen plates 
provided in the kit.  Negative and positive kit controls were diluted 1:30 using sample diluent 
and 100 µl was added to the plates.  Plates were incubated at 4 °C for 16 hours (overnight) 
and then plates washed 3 times with 400 µl of 1X wash solution per well.  Horse radish 
peroxidase (HRP)-conjugated antibody was mixed, then added as directed in the modified 
oral fluid protocol and the plates incubated at 22 °C for 30 minutes.  After washing the plates 
3 times, 100 µl of tetramethylbenzidine (TMB) was added to all wells and incubated for 15 
minutes at 22 °C. The color-developing reaction was stopped by pipetting 100 µl of kit stop 
solution to each well and the absorbance was read
g
 at 650 nm.  Results were reported as 
sample-to-positive ratios (S/P), with responses ≥ 0.40 considered positive.   
 
2.4.2  PRRSV RT-PCR 
Laboratory 1 
RNA was extracted from serum
h 
and
 
oral fluid
j
 using commercial extraction kits and an 
automated magnetic particle processor.
i  
 Serum was extracted following the manufacturer 
instructions, oral fluid was extracted using the protocol for “all other sample types.” 
Real-time PCR was performed
k
 with commercially-available reagent sets
l
.  Master mix 
component volumes per well consisted of 12.5 µl of 2X RT-PCR buffer, 2.5 µl of 10X 
PRRSV primer probe mix, 2.5 µl of 20X multiplex RT-PCR enzyme mix, and 0.35 µl of 100 
copies/ µl of Xeno
TM
 RNA-01 (10,000 copies/µl) internal control.  Ultimately, 18 µl 
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(rounded up) of master mix was combined with 7 µl of RNA extract onto a 96-well PCR 
plate.  The reaction was completed using the following thermal cycling conditions: One cycle 
at 45 °C for 10 min, one cycle at 95 °C for 10 min, 40 cycles of: 97 °C for 2 seconds, 60 °C 
for 40 seconds.  Quality control of the extraction process included negative (nuclease-free 
water) and positive (PRRSV isolate ISU-P) controls, i.e. nuclease-free water and PRRSV 
extraction-positive controls.  Each 96-well PCR plate included a positive amplification 
control
l
 and a negative amplification control (nuclease-free water).   
 
Laboratory 2 
RNA was extracted from serum samples using a commercial extraction kit
h
 and an automated 
magnetic particle processor
i
 following the manufacturer instructions.  Oral fluid samples 
were extracted using a modified version (Protocol “A2”, Chittick et al., 2011) of a 
commercial kit
h
.  Lysis/binding solution was prepared by adding 623 µl of carrier RNA to 40 
ml of lysis/binding solution, without addition of isopropanol.  All other reagents were 
prepared according to the manufacturer’s instructions.  300 µl of oral fluid was added to 450 
µl lysis/binding solution in a 1.5 ml microtube.  Microtubes were vortexed for 3 minutes then 
centrifuged at 16,000 x g for 2 minutes.  600 µl of lysate was added to each well of a deep-
well plate which contained 350 µl of isopropanol and 20 µl of bead mix.. The lysis plate was 
loaded onto the automated particle processor
i
 along with 2 plates of 300 µl of wash solution 
1, 2 plates of 450 µl of wash solution 2, and a final plate of 90 µl of elution buffer. Extraction 
was then completed using program AM_1836_DW_DV_v3. 
Real-time PCR was performed
k 
on serum and oral fluid using real-time RT-PCR PRRSV 
specific reagents for the detection and differentiation of North American & European 
PRRSV viral RNA (cat #TC-9060-096
m) following the manufacturer’s instructions.  The 
reaction was completed using the following thermal cycling conditions: One cycle at 48 °C 
for 15 minutes, one cycle at 95 °C for 2 minutes and 45 cycles of 95 °C for 5 seconds and 60 
°C for 40 seconds.  
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 Laboratory 3 
RNA was extracted from serum
h 
and oral fluid
j
 samples using an automated particle 
processor.
n
 Serum was extracted following the manufacturer instructions, and oral fluid was 
extracted following the protocol for “all other sample types”.  
Real-time PCR was performed
o
 with commercially-available reagent sets.
p
  Master mix 
component volumes per well consisted of 12.5 µl of 2X RT-PCR buffer, 2.5 µl of 10X 
PRRSV primer probe mix, 2.5 µl of 20X multiplex RT-PCR enzyme mix, and 0.35 µl of 100 
copies/ µl of Xeno
TM
 RNA-01 (10,000 copies/µl) internal control.  Ultimately, 18 µl of 
master mix (rounded up) was combined with 7 µl of RNA extract onto a 96-well PCR plate.  
The reaction was completed using the following thermal cycling conditions: One cycle at 45 
°C for 10 min, one cycle at 95 °C for 10 min, 40 cycles of: 95 °C for 2 seconds, 60 °C for 45 
seconds. 
 
Laboratory 4 
RNA was extracted from serum and oral fluid samples using modified versions of a 
commercial kit
h
 and a automated particle processor.
n 
For serum, lysis/binding solution was prepared by combining the lysis/binding solution 
concentrate from the kit (part# 8500G of AM1836
q
) with a lysis/binding solution concentrate 
not provided in the kit (cat# AM8500
q
), isopropanol was not added at this time.  2 µl of 
carrier RNA was then added to 350 µl of the prepared lysis/binding solution concentrate, and 
350 µl 100% isopropanol per reaction.  Wash solution 1 was prepared by adding 12 ml 100% 
isopropanol to the wash solution 1 concentrate provided in the kit (part# 8504G of 
AM1836
q
), and adding 70 ml 100% isopropanol to an additional wash solution 1 concentrate, 
not provided in the kit (cat# AM8504
q
).  Both prepared wash solution 1’s were then 
combined to create the final wash solution 1.  Wash solution 2 was prepared by adding 32 ml 
of 100% ethanol to the wash solution 2 concentrate provided in the kit (part# 8640G of 
AM1836
q
) and adding 160 ml of 100% ethanol to a wash solution 2 concentrate not provided 
in the kit (cat# AM8640
q).  Both prepared wash solution 2’s were then combined to create 
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the final wash solution 2.  300 µl of serum was added to 700 µl of prepared lysis/binding 
solution in a deep-well plate.  The lysis plate was loaded onto the automated particle 
processor
n 
along with 2 plates of 300 µl of wash solution 1, 2 plates of 450 µl of wash 
solution 2, one plate of 90 µl of elution buffer and a deep well tip comb in a deep well plate. 
Extraction was then completed using program AM1836_DW_HV_v3. 
For oral fluid, lysis/binding solution was prepared by adding 2 µl of carrier RNA and 2 µl of 
Xeno
TM
 RNA
q
 (1,000 copies/ µl)
 
to 450 µl of lysis/binding solution per reaction, without 
addition of isopropanol.  All other reagents were prepared according to the manufacturer’s 
instructions.  300 µl of oral fluid was added to 450 µl lysis/binding solution in a deep-well 
plate.  Plates were sealed and vortexed at max speed on a plate shaker for 5 min, then 
centrifuged at 3,300 x g for 5 min.  600 µl of lysate was added to each well of a new deep-
well plate which contained 350 µl of isopropanol and 20 µl of bead mix. The lysis plate was 
loaded onto the automated particle processor
n
 along with 2 plates of 300 µl of wash solution 
1, 2 plates of 450 µl of wash solution 2, one plate of 90 µl of elution buffer and a deep well 
tip comb in a deep well plate. Extraction was then completed using program 
AM1836_DW_300v2. 
Real-time PCR was performed
k
 with commercially-available reagent sets.
l
  Master mix 
component volumes per well consisted of 12.5 µl of 2X RT-PCR buffer, 2.5 µl of 10X 
PRRSV primer probe mix, 2.5 µl of 20X multiplex RT-PCR enzyme mix, and 0.5 µl 
nuclease-free water.  Ultimately, 18 µl of master mix was combined with 7 µl of RNA 
extract onto a 96-well PCR plate.  The reaction was completed using the following thermal 
cycling conditions: One cycle at 48 °C for 10 min, one cycle at 95 °C for 10 min, 40 cycles 
of: 95 °C for 2 seconds, 60 °C for 70 seconds.     
 
Laboratory 5 
RNA was extracted from serum and oral fluid samples using a commercial kit
j
 and 
automated particle processor
r
. Serum was extracted following the manufacturer instructions 
for low-cell-content samples.  Oral fluid samples were extracted using the protocol for “all 
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other sample types”.  300 µl of sample (serum or oral fluid) was used in the reaction and 
reagents were prepared accordingly with one exception: in place of 2 µl of Xeno
TM
 RNA
q
 
(1,000 copies/ µl) control in the lysis/binding solution, 8 µl of in-house control was used.  
Extraction of both sample types was completed using program 4462359_DW_HV.. 
Real time RT-PCR was performed
k 
using an in-house PRRSV RT-PCR assay (cat #TC-9060-
096
m
).  The assay covers two target regions of the PRRSV Type 1 and 2 genes using FAM as 
a reporter dye for the detection of the Type 1 PRRSV and TAMRA as a reporter dye for the 
detection of the Type 2 PRRSV. CY5 was used as a reporter dye for the detection of the 
extraction/inhibition control. 
Serum component volumes per well included 19.25 µl of master mix (includes buffer, primer 
and probes), 0.25 µl of enzyme 1, 0.5 µl of enzyme 2, and 8 µl of extracted serum sample or 
internal control.  Oral fluid component volumes per well included 16.25 µl of master mix 
(includes buffer, primer and probes), 0.25 µl of enzyme 1, 0.5 µl of enzyme 2, and 8 µl of 
extracted oral fluid sample or internal control.  Plates were briefly vortexed (10 sec) and 
centrifuged before being loaded onto the thermocycling instrument. The reaction was 
completed using the following thermal cycling conditions: One cycle at 48 °C for 15 min, 
one cycle at 95 °C for 2 min, 45 cycles of: 95 °C for 5 seconds, 60 °C for 40 seconds 
  
Laboratory 6 
RNA was extracted from serum and oral fluid using a commercial kit
h
 and automated particle 
processor.
n 
 Serum was extracted following manufacturer’s instructions, oral fluid was 
extracted using a modified protocol.  Briefly, lysis/binding solution was prepared by mixing 
235 µl of lysis/binging solution concentrate (cat# AM8500 - not provided in the kit) with 3 µl 
of carrier RNA (1 µg/µl) per sample to be extracted.  Remaining reagents were prepared as 
directed by the manufacturer.  20 µl of bead mix was added to each well of a deep-well plate 
containing lysis/binding solution.  300 µl of oral fluid was then added to each well of the 
same plate followed by 170 µl of 100% isopropanol.  The rest of the extraction procedure 
was completed as directed by the manufacturer. Extraction was completed using the program 
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AM1836_DW_saliva. 
Real-time PCR was performed
k 
with commercially-available reagent sets.
l  
Master mix 
component volumes per well consisted of 12.5 µl of 2X RT-PCR buffer, 2.5 µl of 10X 
PRRSV primer probe mix, 2.5 µl of 20X multiplex RT-PCR enzyme mix, and 0.5 µl Xeno
TM
 
RNA
q
 (1,000 copies/ µl) control.  Ultimately, 18 µl of master mix was combined with 7 µl of 
RNA extract onto a 96-well PCR plate.  Loaded plates were centrifuged at 2,000 rpm for 5 
seconds.  The reaction was completed using the following thermal cycling conditions: One 
cycle at 48 °C for 10 min, one cycle at 95 °C for 10 min, 40 cycles of: 97 °C for 2 seconds, 
60 °C for 40 seconds.  
 
2.5  Statistical Analysis  
Intra-laboratory agreement of oral fluid and serum assay results (ELISA and RT-PCR) 
between all laboratories was compared using Cochran’s Q and McNemar’s test.s   The 
predicted probability of a positive oral fluid test (ELISA or RT-PCR) based on the within-
pen PRRSV prevalence or the number of ‘contact events’ within each pen was calculated 
using logistic regression
t
.  In the logistic model, binary assay results (ELISA or RT-PCR) 
were modeled as the response variable and ‘contact events’ or within-pen prevalence as the 
explanatory variable.  Contact events were grouped by every ten events from 1-100.  The 
resulting probabilities and 95% confidence intervals were plotted in Sigma Plot 11.0
u
  
 
3.  RESULTS 
Testing of the 535 expected PRRSV negative pigs revealed one ELISA positive pig.  Upon 
re-test the sample remained ELISA positive but was RT-PCR negative.  This pen was 
omitted from the ELISA data analysis because it could not be accounted for in the contact 
events for this pen.  2 of the 107 pooled expected negative serum samples tested RT-PCR 
positive by one laboratory.  Individual samples from the respective pools were tested by the 
same laboratory using the same protocols and were all negative.  Therefore the samples were 
considered PRRSV negative for all analyses.   
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3 vaccinated pig serum samples tested PRRSV antibody ELISA negative by all six 
laboratories and 1 vaccinated pig serum sample tested PRRSV RT-PCR negative by all six 
laboratories.  Within-pen PRRSV prevalence and total ‘contact events’ were adjusted to 
reflect the number of vaccinated pigs that tested positive by PRRSV antibody ELISA or 
PRRSV RT-PCR by at least one of six laboratories.  
Intra-laboratory agreement of PRRSV RT-PCR oral fluid testing resulted in greater 
laboratory variation than PRRSV antibody ELISA oral fluid testing (Tables 2, 3, 4 and 5).  
Analysis of intra-laboratory agreement between individual laboratories showed significant 
differences in ten comparisons for oral fluid RT-PCR (Table 4) and six for PRRSV antibody 
oral fluid ELISA. 
Predicted probability plots (Figure 1 and 2) showed comparable probabilities of detection 
between the two assays.  The probability of detection achieved near 100% with 36% within-
pen PRRSV prevalence or ≥ 90 ‘contact events’ per sampling period. 
 
4.  DISCUSSION 
As evidenced by the variation in RT-PCR results among laboratories, improvements need to 
be made to further standardize such assays.  Data were analyzed categorically (positive or 
negative) because no methods exist to standardize continuous quantitative results.  The 
PRRSV antibody ELISA contains internal kit controls that are used to calculate a sample to 
positive ratio, which helps reduce plate-to-plate and lab-to-lab variation.  Similar methods 
may benefit future RT-PCR assays. 
Despite inconsistencies in quantitative data, both assays showed promising categorical 
results.  Predicted probability plots showed predictions near 100% for higher prevalence 
levels and numbers of ‘contact events’.  Predicted probabilities were also significantly better 
than the scenario in which one randomly selected pig were bled and tested on either assay.  
Even if the assumption is that the assays are 100% sensitive and specific, the probability of 
detection is only ~35%.   
For surveillance purposes, detection of low prevalence populations is important.  To achieve 
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better detection the behavior of pigs in the pen must be considered.  It has been reported that 
in a 20 minute sampling period ~70% of pigs in a pen of ~20 pigs will interact with the 
sampling material if one rope is presented to the pen.  If 2 ropes are presented to the pen, 
~90% of pigs were reported to interact with the sampling material.
9
  In this study, vaccinated 
pigs were introduced into study less than 24 hours prior to oral fluid collection.  It is likely, 
that the estimates in this report are conservative because the vaccinated pigs had not 
established social order with in the pen, and may not have interacted with the sampling 
material as much as in a typical setting.  As seen in Figures 1 and 2, predicted probability 
increases dramatically with increased ‘contact events’.  Even in low-prevalence situations, if 
more rope interaction is elicited, better detection may occur. 
This research supports the continuation of studies of oral fluid diagnostics and surveillance in 
veterinary medicine.  Standardized diagnostic methods, a better understanding of pig social 
behavior and refined sample collection protocols will all help to support the ever-changing 
landscape of pig production.   
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Table 1. Vaccinated pig serum (n = 90) RT-PCR and ELISA results, Chochran’s Q p-value 
of ≤ 0.05 indicates significant difference between the testing results from six laboratories 
 
 Percent and Number of Samples to Test PRRSV Positive Cochran’s 
 Q 
p-value 
 Lab 1 Lab 2 Lab 3 Lab 4 Lab 5 Lab 6 Lab 7 Lab 8 
RT-
PCR 
93% 
(84/90) 
93% 
(80/86)* 
93% 
(84/90) 
91% 
(82/90) 
99% 
(89/90) 
97% 
(87/90) 
DNT DNT 0.012 
ELISA 
97% 
(87/90) 
97% 
(87/90) 
97% 
(87/90) 
DNT DNT 
96% 
(86/90) 
96% 
(83/86)* 
96% 
(83/86)* 
0.416 
 
*Missing samples 
  
 
 
6
2 
Table 2. Oral fluid (n = 150) RT-PCR results, Chochran’s Q p-value of ≤ 0.05 indicates significant difference between the testing 
results from six laboratories 
 
PRRSV 
Prevalence 
n 
 Percent and Number of Samples to Test RT-PCR Positive Cochran’s 
 Q 
p-value   Lab 1  Lab 2  Lab 3  Lab 4  Lab 5  Lab 6 
0% 50  0%  (0/50)
 
0%  (0/50)
 
0%  (0/50)
 
2%  (1/50)
 
2%  (1/50)
 
2%  (1/50)
 
0.700 
4% 25  12%  (3/25) 16% (4/25) 12%  (3/25) 8%  (2/25) 20%  (5/25) 20%  (5/25) 0.443 
8% 5  80%  (4/5) 100% (5/5) 80%  (4/5) 20%  (1/5) 100%  (4/5) 80%  (4/5) 0.015 
12% 20  85%  (17/20) 95% (19/20) 55%  (11/20) 55%  (11/20) 100%  (20/20) 90%  (18/20) <0.001 
20% 25  72%  (18/25) 88% (22/25) 40%  (10/25) 32%  (8/25) 80% (20/25) 72%  (18/25) <0.001 
36% 25  96%  (24/25)
 
96% (24/25)
 
76%  (19/25)
 
76%  (19/25)
 
100%  (25/25)
a 
96%  (24/25)
 
0.002 
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Table 3. Oral fluid (n = 145) ELISA results, Chochran’s Q p-value of ≤ 0.05 indicates significant difference between the testing 
results from six laboratories 
 
PRRSV 
Antibody 
Prevalence 
n 
 Percent and Number of Samples to Test ELISA Positive Cochran’s 
 Q 
p-value   Lab 1  Lab 2  Lab 3  Lab 6  Lab 7  Lab 8 
0% 50  2%  (1/50)
 
0%  (0/50)
 
0%  (0/50)
 
0%  (0/50)
 
0%  (0/50)
 
0%  (0/50)
 
0.416 
4% 25  24%  (6/25)
 
16%  (4/25)
 
12% (3/25)
 
8%  (2/25)
 
24%  (6/25)
 
8%  (2/25)
 
0.067 
8% 2  0% (0/5)
 
0% (0/5)
 
0% (0/5)
 
0%  (0/5)
 
0%  (0/5)
 
0% (0/5)
 
1.000 
12% 15  67%  (10/15)
 
60%  (9/15)
 
80% (12/15)
 
47%  (7/15)
 
73%  (11/15)
 
53%  (8/15)
 
0.048 
20% 20  68%  (17/25)
 
88%  (22/25) 92% (23/25)
 
80%  (20/25)
 
92%  (23/25)
 
88% (22/25)
 
0.015 
32% 10  90% (9/10)
 
100% (10/10)
 
90% (9/10)
 
90% (9/10)
 
100% (10/10)
 
90% (9/10)
 
0.722 
  36%* 15  87%  (13/15)
 
93%  (14/15)
 
93% (14/15)
 
87%  (13/15)
 
100%  (15/15)
 
87%  (13/15)
 
0.352 
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Table 4. Intra-laboratory agreement of RT-PCR results, McNemar’s test p-value of ≤ 0.05 
indicates significant difference between laboratories 
 
Laboratory 1 2 3 4 5 6 
1 · 0.039 0.0001 <0.0001 0.013 0.344 
2 · · <0.0001 <0.0001 0.754 0.424 
3 · · · 0.405 <0.0001 <0.0001 
4 · · · · <0.0001 <0.0001 
5 · · · · · 0.180 
6 · · · · · · 
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Table 5. Intra-laboratory agreement of oral fluid ELISA results, McNemar’s test p-value of  
≤ 0.05 indicates significant difference between laboratories 
 
Laboratory 1 2 3 6 7 8 
1 · 0.648 0.302 0.359 0.078 0.804 
2 · · 0.727 0.008 0.180 0.180 
3 · · · 0.002 0.388 0.016 
6 · · · · 0.0001 0.375 
7 · · · · · 0.003 
8 · · · · · · 
66 
 
 
 
 
 
Figure 1. Predicted probability (mean and 95% confidence interval) of detecting a PRRSV 
positive (ELISA or RT-PCR) oral fluid sample by number of ‘contact events’ and relative 
distribution of ‘contact events’ by expected PRRSV prevalence 
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Figure 2. Predicted probability (mean and 95% confidence interval) of detecting a PRRSV 
positive (ELISA or RT-PCR) oral fluid sample by within-pen PRRSV prevalence, and the 
probability of detection if one randomly selected pig in a pen were bled and tested (ELISA or 
RT-PCR), assuming 100% sensitive and specific assays. 
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GENERAL CONCLUSIONS 
The transition of animal production to large-scale confinement- or herd-based systems has 
created opportunities for disease transmission that at one time did not exist.  Increased 
livestock transportation, frequent human-animal contact, the frequency of human travel, and 
dense human populations create countless opportunities for disease outbreak and spread.  
Because of these challenges, it is important to utilize scientifically-based diagnostic and 
surveillance programs to monitor the disease state of animal populations.  Oral fluid samples 
have shown to be a useful biological specimen in surveillance of swine pathogens.  Pen-
based oral fluid specimens can represent a large number of animals with fewer samples than 
serum or other sample types.  Moreover, oral fluid collection is non-invasive, user-friendly, 
and can be done on a regular basis. 
As research on oral fluid use developed, it became apparent that many factors can affect the 
results of specimen testing.  The research presented in this thesis reviewed the current 
knowledge of the external factors that can adversely affect oral fluid diagnostics.  In 
summary, collection material, sample processing and sample storage can have an impact on 
testing for antibodies, pathogens, hormones and proteins.  In the first research chapter 
presented in this thesis, the effect of sample collection material and post-collection sample 
processing was investigated in pig oral fluid samples.  In searching the literature no other 
reports have been produced on this topic.  Though, it was not within the scope of this project 
to elucidate the mechanism(s) responsible for the observed effects, it is clear that there is a 
need for additional research to investigate the present findings. 
Because pig oral fluid samples are commonly collected from pens of animals, it is important 
to understand the limitations of the diagnostic assays being utilized.  The purpose of a 
surveillance program is to detect infection in the early stages.  To accomplish this 
successfully, the diagnostic assay must be able to detect low disease prevalence within the 
population being sampled.  The second research project presented in this thesis examined the 
ability of commercial assays to detect low levels of PRRSV prevalence in a commercial 
production setting.  From the results of this study, it is apparent that disease prevalence is 
only one factor on detecting infection in pen-based samples.  The social behavior of pigs 
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largely influences how frequently each pig in the pig interacts with the sampling material.  
Though the disease prevalence may seemingly be well within the limits of the diagnostic 
assay, if the infected pigs don’t contribute to the sample, infection may not be detected.  
There is a need for further research to understand this aspect of pen-based sampling and 
further improve oral fluid diagnostics. 
All things considered, the value of oral fluid specimens in veterinary and human medicine, 
rationalizes investments in future research to continue discovering how this unique specimen 
can be used to its full potential. 
